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Abstract 
The Kansas Department of Agriculture (KDA) was the United States first state department of 
agriculture. The agency is devoted to the total support of agriculture in Kansas. The department 
works for the entire Kansas agriculture sector, including farmers, ranchers, food establishments 
and agribusinesses. Within this role, the Kansas Department of Agriculture also fulfills its 
responsibility of regulating business functions in accordance with state law. KDA is organized in 
a variety of divisions and programs that provide different services; there are a total of 13 
different departments or services.   
The EpiTrax system is currently utilized through the Kansas Department of Health and 
Environment (KDHE) for maintenance, surveillance and tracking of reportable human health 
diseases in the state of Kansas.  The Department of Agriculture Division of Animal Health wants 
to partner with KDHE to offer a similar system for the tracking and surveillance of reportable 
zoonotic and animal-only diseases.  The Epitrax system employs Disease Investigation 
Guidelines, Disease Fact Sheets and Individual Case Reporting Forms as a way to manage and 
maintain information in a useful manner.  This report presents the details of an internship 
completed at the Department of Agriculture Division of Animal Health (KDA-DAH).  Projects 
worked on during this internship included designing these “Disease Investigation Guidelines”, 
creation of the disease information fact sheets and development and implementation of 
disease case report templates.  These templates are the core structure behind being able to 
online report and track disease information to facilitate disease control through the KDA-DAH.  I 
also participated in general rounds held by the Kansas Department of Health and Environment 
(KDHE).  
The Department of Agriculture Division of Animal Health hosted a Rip Stop exercise during the 
second week in October.  This was a functional exercise designed to portray a “real-life” 
simulation of a Foot and Mouth Disease (FMD) outbreak originating in Alabama and ending up 
at the Kansas State Veterinary Health Center.   This involved all levels of local, state and federal 
agencies; it was designed to monitor the response and management of an FMD outbreak.   
All projects were completed within the internship timeframe and provided valuable experience 
and awareness of the intertwined working relationships at the state level of public and animal 
health. 
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Chapter 1 – Introduction 
Kansas Department of Agriculture 
The Kansas Department of Agriculture (KDA) was the United States first state department of 
agriculture. The agency is devoted to the total support of agriculture in Kansas. The department 
works for the entire Kansas agriculture sector, including farmers, ranchers, food establishments 
and agribusinesses. Within this role, the Kansas Department of Agriculture also fulfills its 
responsibility of regulating business functions in accordance with state law. KDA is organized in 
a variety of divisions and programs that provide different services; there are a total of 13 
different departments or services.   
Division of Animal Health 
The Division of Animal Health was created in 1969 by consolidating all of the activities of: the 
Livestock Sanitary Commission and the State Brand Commission. Currently, it is divided into 
three programs, 1)disease control, 2)animal facilities inspection and 3)brands. As per the 
mission stated on the website, the main goal of the agency is to “ensure the public health, 
safety and welfare of Kansas’ citizens through prevention, control and eradication of infectious 
and contagious disease and conditions affecting the health of livestock and domestic animals in 
the state” (https://agriculture.ks.gov/divisions-programs/division-of-animal-health/).  
Department veterinarians are responsible for testing programs, epidemiology of disease 
outbreaks and technical support for the administration. The Animal Facilities Inspection 
Program regulates companion animal facilities required to be licensed under the provisions of 
the Kansas Pet Animal Act. The Act requires licensing and inspection of all dog and cat breeders 
who produce, offer or sell three or more litters during the state fiscal year, pounds and shelters, 
pet shops, research facilities, distributors, out-of-state distributors, boarding facilities, animal 
rescues and foster homes.  The brands area directs an effective registration and inspection 
program to assist in identifying owners of lost or stolen livestock. 
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Internship Overview 
The internship consisted of a total of 240 on-site hours at the Kansas Department of Agriculture 
Division of Animal Health in Topeka, Kansas. Under the guidance of Dr. Tarrie Crnic, I worked on 
projects for the EpiTrax online monitoring and surveillance system for reportable zoonotic 
diseases and animal diseases.  The internship began September 4, 2013 and ended November 
1, 2013. 
One main project was completed throughout the course of the internship. This large project 
included three subsection pieces for each disease.  The online disease reporting system, 
EpiTrax, is currently utilized by the Kansas Department of Health and Environment to 
coordinate tracking of human diseases; the goal was to extend this program to animal diseases. 
There were three documents that need to be developed in order to make this transition. First, 
is the Disease Investigation Guideline; these were in-depth descriptions of the disease process, 
including the following for each disease: agent, clinical description, reservoir, transmission, 
incubation period, communicability, susceptibility, resistance, treatment, investigator 
responsibilities, managing special situations, data management and reporting.  The second 
piece was a one or two page fact sheet providing a brief overview of the diseases.  This fact 
sheet was to be utilized by investigators in the field to provide to the public.  Finally, was the 
development of the case report templates for guiding investigation questions for entering into 
EpiTrax.  The KDA-DAH has a list of reportable diseases; the diseases I completed throughout 
my experience were as follows: anthrax, brucellosis, contagious equine metritis, equine 
infectious anemia, rabies, vesicular stomatitis, tuberculosis, vesicular exanthema and 
trichomoniasis. 
I was also involved in the Department of Agriculture Division of Animal Health’s Foot and 
Mouth Disease exercise named “Rip Stop” during the second week in October.  This was a 
functional exercise designed to portray a “real-life” simulation of a Foot and Mouth Disease 
outbreak originating in Alabama and ending up at the Kansas State Veterinary Health Center.  I 
was located in the Sim-Cell of the operation; this was the location that monitored all levels of 
the exercise and made sure that activities were continuing as planned.  The Sim-Cell monitored 
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activities of all the locations and players involved and provided injects (activities that spurred 
play) if needed. It was an advantage to be located in the Sim-Cell to be able to observe all 
aspects of play and really have a good understanding of the overall situation. This involved all 
levels of local, state and federal agencies; it was designed to monitor level of response and 
management of a FMD outbreak.   
The internship also provided the opportunity to attend various planning and strategy meetings 
for different sections within the Division of Animal Health: State Trichomoniasis Regulations 
and hearings and Rip Stop Exercise pre and post planning.  
I also participated in general rounds held by the Kansas Department of Health and Environment 
(KDHE). Rounds consisted of a daily overview of any calls that came in to KDHE that specific day.  
Each day an individual is assigned to answer calls and then report at the end of the day any 
situations that may have come up or if any trends may be happening.  This allows all individuals 
involved to understand what is happening around the state and if any further action needs to 
be taken.   
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Chapter 2-  Learning Objectives 
Learning objectives are statements about what an individual can expect to learn by the end of 
an experience. Three learning objectives were identified for my internship with the assistance 
of my internship coordinator and major professor. The specific activities and projects 
completed during the internship evolved and changed throughout its course but the original 
objectives were still fulfilled. 
Objectives: 
1. Understand how zoonotic disease surveillance is or can be incorporated from human 
and animal health agencies. 
2. Understand infectious disease reporting requirements. 
3. Describe the steps of a case investigation and an outbreak investigation. 
Objective one was accomplished through my work on the Disease Investigation Guidelines. I 
was able to apply my veterinary education knowledge not only to develop the guidelines but 
also to develop the case reporting templates to integrate the information in a usable and 
efficient system.  This was also accomplished by researching the importance and relevance of 
zoonotic disease. 
Objective two was accomplished by transitioning the Kansas Department of Agriculture Division 
of Animal Health disease reporting protocols to become integrated into the EpiTrax reporting 
system.  The current EpiTrax system, utilized by KDHE, is suited for human diseases.  The KDA-
DAH collaborates with KDHE on zoonotic diseases, but other animal diseases are also 
monitored.  The Disease Investigation Guidelines and Case Reporting Templates were designed 
to incorporate the animal side of the reporting requirements while molding together the 
human side in order to provide the highest quality of data tracking.    
The last objective was accomplished through the development of the Disease Investigation 
Guidelines and the Case Reporting Templates, but was also accomplished through participating 
in the Rip Stop exercise.  The Case Reporting Templates were created to “walk” the 
investigator, of the suspect case, through the investigation process.  The Rip Stop exercise was 
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a functional description of objective 3; meaning, this was a “real-life” practice of a Foot and 
Mouth Disease outbreak investigation. The monitoring of operation communications and 
coordination, physical protective measures and supply chain integrity and security were 
included for a complete picture of all the steps of an outbreak investigation.  
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Chapter 3 –Importance of Tracking Zoonoses 
Overview 
There is a growing trend to try to understand the linkage between human health, animal 
health and the environment.  Through the integration of human medicine, veterinary medicine 
and environmental science the concept of “one health” was developed to improve the lives of 
all species. The One Health initiative is a movement to unite scientific, environmental and 
health professions, to expound on collaborations between disciplines and try to align world 
health to enhance world human and animal health and safety. This initiative could help save, 
protect and expand knowledge on a world wide scale for years to come.  It allows for a true 
connection among medical disciplines which, in turn, will help save lives of both human and 
animals (www.onehealthinitiative.com). Veterinarians are the individuals working to keep 
animals healthy and are often the front-line defense for disease detection.  They are the 
individuals that will be the first to see and often recognize disease and they are the key to 
prevention and treatment.  Many of these diseases are zoonotic.  Zoonoses are defined by the 
World Health Organization as “diseases and infections which are transmitted naturally between 
vertebrate animals and man” (WHO, 1959). Zoonoses are infections that have multiple hosts 
that include both animals and humans (Cleveland et al 2001). The importance of zoonotic 
diseases cannot be overstated.  A survey completed by Taylor (et al) showed that, of the 1415 
species known to be pathogenic to humans, 61% (868) are zoonotic. While 75% of diseases 
considered to be emerging versus non-emerging are also zoonotic. Zoonotic pathogens causing 
disease in humans can very often cause little or no obvious clinical disease in their animal hosts’ 
(Taylor et al, 2001). The ability of these diseases to go undetected means the role of monitoring 
and surveillance is critical in maintaining public health.  
Tracking of these diseases is crucial; the organization responsible for international 
tracking is the World Organization for Animal Health. This was originally formed by 25 countries 
as the Office of International des Epizootes (OIE) in response to an outbreak of rinderpest in 
Europe.  It is still known as OIE and now consists of over 170 countries with its main goal to 
inform countries of disease that could endanger human or animal health.  OIE also maintains 
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data on what diseases are currently located in different areas as well as if a country is disease 
free of certain diseases (www.oie.int).  Tracking of disease is vital in order to better understand 
prevention efforts, enable health professionals to make timely and accurate decisions on 
treatment and management and to quantify the burden of zoonoses.  In order to appropriately 
respond, health professionals need to be able to track and manage the diseases that are 
prevalent as well as be able to recognize as soon as possible outbreak occurrences.   
Diseases emerge for many different reasons with regards to both human and animal 
health. Many of the reasons are intertwined and include increasing human population, 
increasing numbers of food producing animals, climate change and an ever-changing 
environment. Travel is also much easier and more prevalent than in the past and illegal 
movement of animals and animal by-products continues to be a problem (Wood et al 2012).  
Human infections can be a warning of disease risk to animals and vice versa. Many pathogens 
do not cross infect, but as time continues organisms can mutate and adapt to new 
environments and allow them to cross species lines where they may not have previously.  The 
relationship between the environment, infectious disease and health outcomes for humans and 
animals can all be inter-related.  
There are many reasons why zoonoses need to be considered serious threats to public 
health.  First, a disease that starts as zoonotic may have the potential to develop into a major 
human communicable disease.  Bennett and Begon (1997) highlight this regarding some viral 
diseases. Some communicable diseases cannot sustain themselves in the human population 
below a critical minimum population size or density.  These conditions that are prime for 
development were not established until more recently (last few thousand years); with 
continued population growth these previously “quiet” diseases have found footing and have 
become able to grow and adapt from other species.  This is not true for all communicable 
diseases, but is true for a few very important diseases in human history including, influenza and 
AIDS (although HIV can now sustain itself entirely in the human population) (Grant and Olsen 
1999).  Over time, as populations grow and change, communicable and zoonotic diseases will 
shift, thus they need to be seriously considered in order to minimize the threat to public health.  
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An important way to control human risk from zoonoses is to be constantly vigilant in 
monitoring and surveillance for possible infections.  The majority of veterinarians and human 
medical professionals have a basic knowledge of zoonoses and have some understanding of the 
threat they may pose to human health.  In practice many health professionals either fail to 
consider the possibility that they may be dealing with zoonoses or ignore the implications of 
these types of infections on public health (Cripps, 2000).   
As the population continuously increases there is a rise in food demand, which leads to 
new areas for food production and development.  Increasing animal trade for food is also 
contributing to the spread of zoonoses.  Humans are traveling more frequently and in all areas 
around the world allowing for more exposure to the possibility of zoonoses (Seimenis 1998).   
Numerous zoonoses are considered biological agents for use by terrorists and provide 
an additional reason for in-depth plans of tracking and surveillance.  Many zoonotic diseases 
have been utilized as biological weapons, including anthrax, plague, botulism and brucellosis 
(Ryan 2008).   As programs are developed to help protect humans and animals from naturally 
occurring disease, attention also needs to be paid to protect from biological warfare agents. 
Broad interdisciplinary approaches are needed to better understand the complex 
interactions of factors that act together to increase or reduce risks to animal and human health.  
In the One Health Initiative a unified approach between veterinary and human medicine is used 
to improve global health for people and animals’.  It’s the responsibility of every veterinary and 
medical professional to work together to battle against zoonotic diseases across the globe. The 
problem of zoonoses is multi-factorial with one of the major constraints in controlling zoonoses 
being the lack of resources. However, much can be done by education, and in particular by 
increasing the awareness of different health professionals, and facilitating communication and 
collaboration between veterinary, public health and human health personnel. This will help us 
to approach and control zoonotic diseases in as efficient and effective a way as possible. 
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Chapter 4 EpiTrax 
In spring of 2012, the Kansas Department of Health and Environment (KDHE) went live with 
their new electronic disease surveillance system, EpiTrax. This system replaced KS‐EDSS. 
EpiTrax is an open source, highly configurable, comprehensive surveillance and outbreak 
management application designed for public health. It allows local, state, and federal agencies 
to identify, investigate, and mitigate communicable diseases, environmental hazards, and 
bioterrorism events. EpiTrax supports electronic laboratory reporting (ELR) and offers 
sophisticated analysis, visualization, and reporting of contact and case information. EpiTrax 
increases overall effectiveness in preventing morbidity and mortality through decreased 
reporting time, automated assignment and routing processes, easy form creation tools, trend 
analysis, detection of anomalies and quality assurance.  
 
Certain infectious disease must be reported to KDHE and KDA-DAH.  They receive these reports  
by phone, mail, or fax. They reports are sorted and routed to the appropriate section. 
The KDA-DAH currently tracks information for their reportable diseases via database with 
hardcopies as back-up.  In order to be better prepared, the department needs to be able to 
manage, report, track and provide surveillance in a quick and efficient manner.  KDA-DAH needs 
to be able to get accurate and quality information quickly to individuals in the instance of an 
outbreak or suspect case of bioterriosm; in order to meet this need, the EpiTrax system is going 
to be utilized by KDA-DAH.  This would provide an opportunity for KDA-DAH and KDHE to work 
together in cases of zoonotic disease.  KDA-DAH will also be able to efficiently have access to 
information on previous cases, current cases and have the most current information on 
diseases affecting public health through the EpiTrax system.  My internship produced 
background information data entry templates and reporting guideline for 9 pathogens of 
concerns for KDA-DAH (anthrax, brucellosis, tuberculosis, vesicular exanthema, vesicular 
stomatitis, rabies, equine infectious anemia, contagious equine metritis, trichomoniasis) 
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Chapter 5 Rip Stop 
Foot and Mouth Disease FMD 
The purpose of the exercise was to present a real-life scenario that would initiate a state and 
local response to an agriculture emergency.  The state of Kansas has been preparing for many 
years to respond to a foreign animal disease (FAD) issue within the state as well as a 
preventative response to keep it from entering the state.  Kansas State University, the land 
grant university within the state, has been involved throughout this planning process.  Its role 
has been primarily to support the state’s response.  This exercise was designed to look directly 
at KSU’s response to a FAD on campus and its impact on areas outside of animal agriculture 
programs.  In addition, the exercise focused on the state’s response and the cooperative and 
coordinated responses between state, local and university resources.   
The exercise was a functional exercise, planned for 2 days at multiple locations in the state of 
Kansas, including Topeka, Manhattan, Riley County, Pottawatomie County and Woodsen 
County.  Exercise play was limited to the interactions between participating functional areas 
and the Simulation Cell (Sim Cell).  Over the course of the two days, the scenario and associated 
injects established a learning environment for federal, state, and local agencies to practice their 
response protocols.  Injects were fictional activities or processes that were implemented to 
monitor the response and/or to provide an additional element to the exercise that hadn’t been 
considered.  For example, one inject, in the exercise, was for the simulation cell to execute a 
tornado warning for the Manhattan, KS area and then to analyze the response from the various 
players.  The exercise was not an inspection and was conducted in a no-fault atmosphere.  
However, the functional nature of the exercise provided evaluators an opportunity to 
meaningfully evaluate player actions regarding current plans and capabilities.    
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Rip Stop 
Locations of Play 
 
Exercise play was conducted at the following locations: 
SimCell 
109 SW 9th Street, 4th Floor (Kansas Department of Agriculture [KDA]) 
Topeka, Kansas 
Point of Contact (POC) during exercise: Jami Grace 785-221-8414 
 
Kansas State Emergency Operations Center (SEOC) 
2800 SW Topeka Boulevard 
Topeka, Kansas 
POC: Jonathon York 785-274-1406 
 
Movement Control Branch 
Building #282 Forbes Field 
Topeka, Kansas 
POC: Sherry Turvey 785-862-2415 
 
KSU Veterinary Health Center (VHC)/Veterinary Diagnostic Laboratory (VDL) 
KSU, Mosier Hall 
1800 Denison Avenue 
Manhattan, Kansas 
POC: Dr. Shirley Arck 785-313-4020 
ldout RIP STOP October 4, 2013 
KSU Emergency Operations Center (EOC) 
KSU, Edwards Hall (Basement) 
Denison Avenue 
Manhattan, Kansas 
POC: Steve Galitzer 785-532-5856 
 
KSU Animal Sciences and Industry (ASI) EOC 
KSU, Call Hall 
Mid Campus Drive, 
Manhattan, Kansas 
POC: Dr. Larry Hollis 785-532-1246 
 
KDA Unified/Area Command, Movement Control Branch, Disease Control Branch, Public 
Information Officer/Joint Information Center (separate rooms) 
Biosecurity Research Institute (BRI) – Pat Roberts Hall 
Denison Avenue, 
Manhattan, Kansas 
Government-issued identification required for entry 
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POC: Craig Beardsley 783-532-3352 
 
Riley County EOC 
Law Enforcement Center 
1001 South Seth Child Road 
Manhattan, Kansas 
POC: Pat Collins 785-537-6333 
 
Potawatomie County EOC (initially co-located with Riley County at the Riley County EOC) 
106 North 1st Street 
Westmoreland, Kansas 
POC: Chris Trudo 785-457-3358 
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Rip Stop 
Core Capabilities 
 
This functional exercise focused on the following core capabilities: 
1. Operational Communications - Ensure the capacity for timely communications in support 
of security, situational awareness, and operations by any and all means available, among 
and between affected communities in the impact area and all response forces. 
2. Operational Coordination - Establish and maintain a unified and coordinated operational 
structure and process that appropriately integrates all critical stakeholders and supports the 
execution of core capabilities. 
3. Physical Protective Measures - Reduce or mitigate risks, including actions targeted at 
threats, vulnerabilities, and/or consequences, by controlling movement and protecting 
borders, critical infrastructure, and the homeland. 
4. Supply Chain Integrity and Security - Strengthen the security and resilience of the supply 
chain. 
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Rip Stop 
General Guidance for a Functional Exercise 
There was a minimum of nine functional areas participating in this exercise, over a two-day 
period involving approximately 300-350 individuals. The involvement of many of these 
functional areas was predicated by actions taken by other functional areas. Because of this, it 
was important for all participants to realize that while they may not have been immediately 
engaged in the exercise at the start on day one, they became engaged in the exercise sometime 
later. For example, KDA  became engaged in the exercise with the initial injects; however, the 
two functional areas representing Riley and Pottawatomie Counties did not become engaged in 
the exercise until they were called upon by the state, the university, or a concerned citizen. 
Therefore, it was critical that all players not immediately engaged in the exercise were ready to 
respond as soon as they were contacted by the appropriate entity. This also provided realistic 
simulation of initial response times. While the controller and evaluator for a functional area 
were present at the exercise venue, they expected the participants in that functional area to 
conduct normal business until they were drawn into the exercise. In addition, this was a 
functional exercise. All players were reminded that action must be taken up to the point of 
moving equipment or personnel. This commitment of resources was tracked in detail and any 
real-time constraints on deployment were observed. For example, if law enforcement units 
were to be dispatched to a quarantine, the officers, units and other associated supplies were 
detailed and the travel time for the resources were accounted for (had passed) before these 
resources were active in the response. If the law enforcement units took two hours to arrive 
and set up the road block, the road in question was considered open for two hours and the 
resources deployed could not do any other job until they were demobilized. To further 
reinforce this aspect and condition of the exercise, all participants were invited to participate in 
a conference call, approximately one week prior to the exercise, where this aspect of the 
exercise was explained and discussed.  
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Chapter 6 - Reflection  
The Internship 
Overall I feel that this internship was a valuable experience for me and gave me good insight 
into the field of public health at the state government level. My biggest challenge was to 
prioritize each disease and ensure I had time to complete them all within the time frame of the 
internship. I enjoyed being a part of the Rip Stop functional exercise the most as it was more 
hands on and I had the opportunity, being in the Sim Cell, to really get an overview of all the 
areas participating. It was easy to see which departments or participants had prepared and 
knew what was in place and how to implement protocols.   
I also enjoyed developing the Disease Investigation Guidelines, Fact Sheets and Templates for 
Case Reporting and investigations.  I feel like it was an excellent use of my veterinary education 
and background.  It also gave me the opportunity to meet and work with individuals throughout 
the Division of Animal Health, including state veterinarians, livestock commissioner and those 
vets that had been through FADD training.  It was a great networking opportunity and a 
wonderful benefit to have these individuals in the offices surrounding my own.  I also enjoyed 
being a part of the Trichomoniasis legislation meetings and sitting in on the hearings with 
producers, livestock markets and veterinarians. 
Another valuable part of the internship was the opportunity to attend and participate in office 
meetings. This included having the opportunity to sit in on the KDHE topic rounds daily.  Those 
rounds discussions were often the highlight of the day and I found myself including information 
from those within the projects I was working on.    
The internship was a useful addition to the coursework I have completed in the Master in Public 
Health as well as an excellent complement to my veterinary education. The internships allowed 
me to take the courses and information and turn them into “real life” situations with the Rip 
Stop exercise and to utilize my background to develop documents that could help in numerous 
aspects of public health tracking, monitoring and surveillance.   Another important aspect that I 
learned was about funding and what it truly would take to manage an outbreak of FMD.  The 
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KDA spent over 110,000 dollars to organize, plan, and execute the Rip Stop exercise; that was 
just to have the exercise, not including what would happen to the state if there was an 
outbreak of FMD.   
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CASE DEFINITION (CDC 2010) 
Clinical Description for Public Health Surveillance: 
A systemic toxemic disease caused by Bacillus anthracis.  It can affect all domestic animals, but 
is most common in ruminants(cattle, sheep and goats are most susceptible, horses 
intermediate, pigs and dogs are generally resistant, wild ruminants are susceptible).  Sudden 
death may often be the only sign.  In ruminants, high fever is usually seen and death within 1-2 
days.  A few animals will exhibit staggering, depression, dyspnea leading to collapse and 
convulsions.  Pregnant cows may abort, milk production can suddenly decrease and often 
swelling of the neck and thorax is seen.  Post mortem signs seen include rigor mortis that is 
incomplete and the spleen is often extremely large with a jelly-like consistency that may exude 
thick, dark or black colored blood when cut.  Lymph nodes are generally large and hemorrhage 
and edema are common with rapid decomposition.  Necropsy on suspect animals is not 
recommended. Tissues from suspected cases should not be exposed to air due to the long term 
bioavailability of the spores.   
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Case Classification 
Confirmed: A clinically compatible illness with one of the following:  
• Culture and identification of B. anthracis from clinical specimens 
• Documented anthrax environmental exposure 
• Evidence of B. anthracis DNA (polymerase chain reaction) in clinical specimens 
collected from a normally sterile site (ideal is aqueous humor) or lesion of other affected 
tissue (skin, pulmonary, reticuloendothelial, or gastrointestinal). 
Probable:  A clinically compatible illness that does not meet the confirmed case definition, but 
with one of the following:  
• Epidemiological link to a documented anthrax environmental exposure;  
Suspected: An illness that is suggestive of one of the known anthrax clinical forms but no 
definitive, presumptive, or suggestive laboratory evidence of B. anthracis, or epidemiologic 
evidence relating it to anthrax. 
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LABORATORY ANALYSIS— 
• Culturing B. anthracis from clinical specimens remains the gold standard and in animals 
preferred specimen is aqueous humor  
IMPORTANT: Upon verification of B. anthracis, the laboratory who handled any specimens or 
isolates must use appropriate forms to report the identification or verification of the select 
agent or related toxins and of the final disposition of that identified agent or toxin and the 
specimens that were presented for diagnosis, verification, or proficiency testing, as well as any 
seizure of the select agents or toxins by federal law enforcement agencies. Refer to: 
www.selectagents.gov 
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EPIDEMIOLOGY 
Anthrax is a serious zoonotic disease; humans are accidental hosts. In the developed countries, 
anthrax is infrequent and sporadic, and is primarily an occupational hazard of workers who 
process hides, wool, hair and bone and of veterinarians, agriculture and wildlife workers who 
handle infected animals. Human anthrax is endemic in the agricultural regions of the world, 
such as Africa, Asia and the Middle East. Livestock are at risk of infection from animal feed 
containing contaminated bone meal as well as movement of soil where spores are located. 
Anthrax has been used as a bioterrorist agent.   
DISEASE OVERVIEW 
A. Agent: 
Bacillus anthracis is a gram-positive,  aerobic, encapsulated, spore-forming, non-motile rod. The 
spores are resistant to heat, sunlight, drying and many disinfectants.  Spores need to be 
exposed to air to become active. 
B. Clinical Description: 
Signs include acute death, enlarged lymph nodes and spleen that when cut exudes dark black 
blood.  Bleeding can be seen from remaining body orifices.  In humans there are three main 
clinical presentations of anthrax: 
Cutaneous: The most common clinical presentation. Initial itching at the affected site is 
followed by a lesion that becomes papular then vesicular, developing in 2-6 days into a 
depressed black eschar.  
Inhalational: Initial symptoms are mild and nonspecific and may include fever, malaise, and mild 
cough or chest pain; acute symptoms of respiratory distress, including stridor, sever dyspnea, 
hypoxemia, diaphoresis, shock and cyanosis and death shortly after.  
Gastrointestinal: Lesions lie at any point of the intestinal tract and are ulcerative and massively 
edematous, leading to hemorrhage, obstruction, perforation and extensive ascites. Abdominal 
distress is characterized by pain, nausea and vomiting followed by fever, signs of septicemia, 
and death. A rare oropharyngeal form is characterized by edematous lesions, necrotic ulcers 
and swelling in the oropharynx and neck. 
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All forms of anthrax if untreated can develop into systemic illnesses that include fever, shock, 
and meningitis that is usually fatal. 
C. Reservoirs: 
B. anthracis usually occurs in limited geographic regions.  Most common reservoirs are usually 
hoofed animals. Spores are produced when exposed to air and can remain viable for years in 
soil or in hides of infected animals.  
D. Mode(s) of Transmission: 
Disease spreads through animals by contaminated soil, feed, and possibly biting flies.  Human-
to-human transmission is extremely rare and has only been reported in the cutaneous form.  
E. Incubation Period:   
In animals it is 1-20 days but infections typically become apparent in 3-7 days.  
 In humans it is usually 1-7 days, but periods up to 60 days are possible. 
F. Period of Communicability: 
Large populations of bacteria can be present in the blood and carcasses; products made from 
hides of infected animals and soil contaminated with the spores may remain infectious for 
decades. 
G. Susceptibility and Resistance: 
Susceptibility is determined by occupation and geographic location; there is some evidence of 
inapparent infection among those in frequent contact with the agent.  
H. Treatment 
Animals can be treated with antibiotics, primarily oxytetracycline, and supportive care; sick 
animals should be isolated.  Deceased animals should be incinerated as well as bedding, 
manure and contaminated food and other materials that were in contact with the 
contaminated animal.  
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I. Vaccine:  In endemic areas there is a modified live vaccine available for livestock; it is not 
recommended to vaccinate and utilize antimicrobials at the time of an outbreak due to the 
vaccine being modified live.   
 
NOTIFICATION TO PUBLIC HEALTH AUTHORITIES 
As a potential bioterrorism agent, all confirmed or suspected anthrax cases shall be reported 
within 4 hours by phone: 
1. Health care providers and hospitals: report to the local public health jurisdiction, KDA-
DAH or KDHE-BEPHI (see below)  
2. Local public health jurisdiction: report to KDA-DAH and KDHE-BEPHI (see below) 
3. Laboratories: report to KDA-DAH or KDHE-BEPHI (see below) 
4. KDA-DAH or KDHE-BEPHI will contact the local public health jurisdiction by phone 
within one hour of receiving any suspected anthrax report. 
Kansas Department of Agriculture-Division of Animal Health (KDA-DAH) 
Phone: 1-785-296-2326 
Fax: 1-785-296-1765 
 
Kansas Department of Health and Environment (KDHE) 
Bureau of Epidemiology and Public Health Informatics (BEPHI) 
Phone: 1-877-427-7317 
Fax: 1-877-427-7318 
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Further responsibilities of state and local health departments to the CDC: 
As a nationally notifiable condition, anthrax cases require an IMMEDIATE, EXTREMELY URGENT 
or IMMEDIATE, URGENT report to the Center of Disease Control and Prevention (CDC) 
depending on the circumstances. 
1. An anthrax case whose 1) source of infection is unknown; 2) is recognized as 
bioterrorism exposure/potential mass exposure; or 3) is a serious illness not responding 
to treatment represents a situation requiring IMMEDIATE, EXTREMELY URGENT 
reporting.  
• KDHE epidemiologist must call the CDC EOC at 770-488-7100 within 4 hours of a being 
notified of the confirmed or probable case.  
• KDHE-BEPHI will notify the Local public health jurisdiction immediately to coordinate 
on follow-up for the report information needed to complete the electronic form before 
the next business day. 
• KDHE-BEPHI will file an electronic case report the next business day. 
2. An anthrax case that is naturally-occurring or occupational and is responding to 
treatment requires IMMEDIATE, URGENT reporting. 
• KDHE epidemiologist to call the CDC EOC at 770-488-7100 within 24 hours of a case 
meeting the confirmed or probable criteria.  
• Local public health jurisdiction will report information requested on the disease 
reporting forms as soon as possible, completing the forms within 7 days of receiving a 
notification of an anthrax report.  
• KDHE-BEPHI will file an electronic case report the next regularly scheduled electronic 
transmission.  
(KDHE-BEPHI files electronic reports weekly with CDC.) 
 
 
 
 
 
 
31 
 
Anthrax 
Disease Management and Investigative Guideline 
INVESTIGATOR RESPONSIBILITIES 
1) Use current case definition, to confirm diagnosis with the medical provider. 
2) Conduct a case investigation to identify potential source of infection.  
3) Conduct contact investigation to identify additional cases. 
4) Identify whether the source of infection is major public health concern. 
• Source is unknown, or bioterrorism or mass exposure is indicated 
• Serious illness not responding to treatment 
5) Initiate control and prevention measures to prevent spread of disease. 
6) Complete and report all information requested via the state electronic surveillance system. 
7) As appropriate, use the disease fact sheet to educate individuals or groups. 
 
STANDARD CASE INVESTIGATION AND CONTROL METHODS 
Case Investigation 
1.  Contact the medical provider who ordered testing of the case or is attending to the case and 
obtain the following information. (This includes medical records for hospitalized animals.)  
• Using the Case Report Form, identify any symptoms of anthrax: 
− Record earliest onset date, noting the first symptom. 
− Record any other symptoms experienced. 
• Examine the laboratory testing that was done to ensure all testing that could confirm the case 
has been reported in Epi-Trax. 
• Examine and record the therapy that the case received. 
• Record outcomes: recovered or date of death 
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2.  Interview the case or proxy to determine source and risk factors; focus on a 6 week 
incubation period prior to illness onset. 
3.  Investigate epi-links among cases (clusters, household, co-workers, etc.).  
• For suspected outbreaks go to Managing Special Situations section. 
 
Contact Investigation 
1) Any person in contact with the source of infection is defined as a contact. This may include 
physical contact with an infected animal or a contaminated product, ingestion of contaminated 
food, or inhalation of aerosolized spores.  
• Any exposure that results in a suspected case of anthrax requires a public health 
investigation to identify if other exposures in the same setting might have led to other 
cases of anthrax.  
2) Examine all potential exposures based on the possible source and potential modes of 
transmission to define who may be at-risk.  
3) Identify those who participated in at-risk activities and contact them to identify if they are 
experiencing any symptoms.  
4) Investigate the clinical laboratory that handled the B. anthracis isolate to ensure standard 
procedures were in place to minimize the risk of transmission. 
Isolation, Work and Daycare Restrictions 
1) Hospitals: Standard precautions (contact precautions for wound care); no isolation required. 
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Case Management 
Report on any changes in patient status (i.e., discharge, death). 
Contact Management 
1) Symptomatic acquaintances, household members, associates, or co-workers should be 
strongly urged to contact their physician for a medical evaluation and are followed-up as 
suspect cases. 
2) Contact Monitoring:  
• Depending on type of exposure, asymptomatic animals who were potentially exposed 
should continue to be monitored for clinical signs. 
• A veterinarian should be consulted immediately if symptoms develop.  
3) Exposure circumstances direct decisions on prophylaxis and/or vaccination not the test 
results. 
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Environmental Measures 
1) Animal or meat product as sources of infection: 
• Verify the location, or previous location, of the source of infection (i.e., state or country of 
origin of meat or animal product). 
• Implicated food items must be removed from the environment. If a commercial food item is 
implicated or if any domestic animal(s) that reside in the state of Kansas is affected by anthrax, 
the Kansas Department of Agriculture- Division of Animal Health should be notified 
immediately (785-296-3556). 
Education 
1) Use fact sheets and materials from CDC (www.bt.cdc.gov/agent/anthrax/) to educate 
individuals and groups. 2) Educate workers who handle potentially contaminated articles about 
the modes of anthrax transmission and disease prevention methods, including care of skin 
abrasions, general hygiene, other personal protective measures, appropriate carcass disposal 
and barrier precautions.  
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MANAGING SPECIAL SITUATIONS 
A. Outbreak Investigation: 
A single case of inhalation anthrax is so unusual that it should be reported and investigated 
immediately as a potential bioterrorist event. Two or more cases of cutaneous or 
gastrointestinal anthrax with a common source or suspected common source should be 
investigated as an outbreak with adequate resources applied to the investigation. 
1) Consider the possibility of an outbreak when there is an unusual clustering of cases in time 
and/or space 
2) Notify KDA-DAH (1-785-296-3556) or KDHE (1-877-427-7317) immediately. 
3) Active case finding will be an important part of any investigation. 
B. Intentional Contamination 
Anthrax is a potential bioterrorism weapon; inhalation of aerosolized spores is of the highest 
concern. A single case of inhalation anthrax is so unusual that it should be reported and 
investigated immediately as a potential bioterrorist event. Other forms of anthrax whose case 
has no remarkable travel history and is not employed in an occupation that is prone to 
exposure, should result in an intentional event being considered. Because the laboratory 
confirmation could be delayed, specific epidemiological, clinical, and microbiological findings 
that suggest an intentional release of anthrax should result in the issue of a health alert and the 
proper notifications. 
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Safety Considerations: 
• Anthrax is not transmitted person-to-person.  
• Greatest risk to human health occurs during the period or primary aerosolization in which 
anthrax spores remain airborne thus it is not recommended to open the carcass of suspect 
animals.   
• Response personnel are not likely to be at risk during the investigation. A possible exception 
would be a mechanism designed to disseminate spores into an enclosed space over an 
extended period of time. 
• Decontamination: Any facilities or equipment coming in direct physical contact with a 
substance alleged to be anthrax should be thoroughly washed with disinfectant. Removable 
equipment (halters, lead ropes, etc…) should be placed in a plastic bag, sealed, and labeled. 
Risk Communication Materials: 
• Factsheet for anthrax 
• Communicating in the First Hours: www.bt.cdc.gov/firsthours/anthrax/ 
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Surveillance: 
• Arrange for active surveillance for 60 days for the development of signs and symptoms of 
anthrax among all animals exposed. 
Diagnosis of Anthrax Infection: 
• Veterinarians who suspect anthrax should take immediate steps for protection of humans by 
instigating isolation of suspect animals utilizing appropriate precautions and notify local 
authorities as well as the KDA-DAH.  Alert the laboratory to the possibility of anthrax and the 
need for special safety procedures and guidance on correct methods for acquiring and 
submitting samples.  Laboratories should consult with state public health entities prior to or 
concurrent testing protocols.  
• Microbiological findings: Peripheral bloods smear or collection of aqueous humor  with gram-
positive bacilli or blood culture growth of large gram-positive bacilli with preliminary 
identification of Bacillus sp. Other rapid assays may also be available. 
• Pathological findings: hemorrhagic mediastinitis, hemorrhagic thoracic lymphadenitis, 
hemorrhagic meningitis; or DFA stain of infected tissues 
DATA MANAGEMENT AND REPORTING TO THE KDA-DAH and KDHE 
A. Organize, collect and report data.  
B. Report data via Epi-Trax. 
• Especially data collected during the investigation that helps to confirm or classify a case.  
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Anthrax Fact Sheet 
 
Introduction 
Anthrax is a potentially fatal disease of all animals caused by the spore-forming bacterium 
Bacillus anthracis. Species susceptibility varies. Cattle, sheep and goats are considered highly 
susceptible to anthrax, horses are intermediately susceptible, pigs and dogs are generally 
resistant, and birds are considered highly resistant. Anthrax is common in Africa and Asia with 
outbreaks also occurring in the USA. States that have had outbreaks include: Texas, Minnesota, 
Montana, California, Colorado and both North and South Dakota.  
 
Anthrax Agent 
The anthrax bacterium is found in two forms – the vegetative form and the spore form. The 
vegetative form grows and reproduces in the animal; exposure of this vegetative form to 
oxygen causes sporulation.  The spores contaminate the environment and may remain viable in 
the soil for decades. The spores are resistant to temperature changes (extreme heat or cold), 
most disinfectants and drying. The spores can survive in water up to 2 years. Carcasses will 
rapidly decompose and thus destroy the vegetative form of the bacterium.  
 
Transmission 
Transmission in animals typically occurs by ingestion of soil contaminated with spores. Animals 
may directly ingest the spores from grazing or from feed that has been grown on anthrax-
infected soil. Exposure will increase in times of flooding, drought of after disruption of the soil 
(tilling or plowing).  Once these spores are ingested they revert to the vegetative form and can 
produce toxins within the animal.  Some animals may develop a localized reaction/infection by 
exposure via breaks in the skin.  
 
Clinical Signs in Ruminants 
Ruminants are the most susceptible to anthrax with rapid onset of symptoms or death.  Sudden 
death may occur with no other signs; or the animal may have a high fever, stagger, tremble, 
collapse with difficulty breathing or seizure. These animals will bloat very rapidly after death 
and may have a bloody discharge from mouth, nose, anus or vulva.  The most notable sign is 
the lack of rigor mortis after death.  Necropsy is NOT recommended! (due to the possibility of 
releasing spores) This is especially important in areas where anthrax is present (states listed 
above). Take precautions and call your veterinarian immediately.   
 
Clinical Signs in Horses 
Generally horses will develop acute clinical signs including: fever, anorexia, depression, colic, 
and bloody diarrhea. Edema may also be present in the neck, sternum, lower abdomen and 
external genitalia.  Death most often occurs within 1-3 days (some may survive up to a week).  
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Clinical Signs in Pigs 
Pigs typically have localized swelling in the neck that may progress to swelling in the throat 
causing difficulty in breathing and swallowing.  Often they will have a fever, enlarged lymph 
nodes and loss of appetite. The disease may be mild to chronic with some pigs recovering with 
no clinical signs.  These pigs will often have localized infection of the tonsils and lymph nodes 
found at slaughter.    
 
Diagnosis and Treatment 
In areas that are prone to the disease, anthrax should always be on the differential diagnosis 
list.  A veterinarian should rule out anthrax on any suspect cases before the carcass is handled 
by anyone else. A diagnosis is confirmed by positive identification of the bacteria in samples 
from the dead animal, either microscopically or via fluorescent antibody test. The optimal 
sample for diagnosing anthrax in dead animals is aqueous humor aspirated from the eye-
remember- no necropsy! 
 
Control 
 Quarantine of the premises should be instituted immediately 
 Carcasses should be burned or deeply buried; this includes bedding, manure and other 
materials- (check with local regulations governing disposal) 
 Appropriate decontamination of pens, panels and equipment using a solution of 10% 
sodium hydroxide or 5% formaldehyde  
 Isolate other sick animals 
 Prevent scavenger animals access to the carcass 
 Vaccination may be an option on exposed animals  
 Restrict grazing in pastures that are known to be contaminated 
 
Prevention 
Annual vaccination of livestock in anthrax endemic areas with a modified live anthrax vaccine 
may aid in prevention of the disease. Initially a two-dose series is recommended with annual 
boosters to follow. 
 
Zoonotic Potential 
Anthrax is not known to spread from human to human, but humans who handle products from 
infected animals or by inhaling the spores (even from dried hides) are the main forms of 
transmission.  Anthrax can also be spread by eating undercooked meat from infected animals. 
Anthrax spores can and have been used as a bioterrorist weapon. Since anthrax has been sent 
through the USPS protocols have been developed for individuals involved in all aspects of mail 
handling.  
For information on anthrax in humans, contact the local County Public Health Department or 
visit: http://www.kdheks.gov/epi/disease_investigation_guidelines.htm  or 
http://www.cdph.ca.gov/healthinfo/discond/Pages/Anthrax.aspx 
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This fact sheet is for information only and is not intended for self-diagnosis or as a substitute 
for consultation. If you have any questions about the disease described above or think that your 
animal may have an infection, consult with your veterinarian. 
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Case Report Anthrax 
Demographics 
Case # 
Investigator- 
 Name 
 Email 
 Phone # 
Veterinarian-  
  Name 
 Address 
  Cell # 
 Work # 
 Email 
 Clinic name 
Owner- 
 Date reported 
 Name 
 Address 
 County 
 DOB 
 Home # 
 Cell # 
 Work # 
 Email 
 Gender 
 Primary language 
Other Contacts- 
Any other humans in contact with suspect animal? 
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 Name 
 Address 
 Phone 
 Date of contact with suspected animal 
 Type of contact 
Animal Demographics 
Species 
Breed 
Gender 
State of Origin 
Age at disease onset 
Quarantined 
Deceased 
Was animal euthanized- 
 If yes, method of euthanasia used 
 Carcass disposal? 
  How, when, where 
Were other animals exposed to the suspect animal 
 If yes, are they sick or showing the same clinical signs or dead 
 If no, were they isolated from the suspect animal 
Are other animals eating the same forage (same pasture) or the same feed as the suspect 
animal? 
If yes, where are the pastures or where was the feed purchased 
 
Exposure History 
How long has the animal been owned by the current owner? 
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Where did owner get animal? 
Other animals that are in contact with currently sick or dead animal? Please describe 
 If yes, what species, how many, type of contact 
Other animals with the same or similar clinical signs 
 If yes, please complete an additional form for each animal 
Any other animals before now (days, week, months, years) become sick or die with similar 
clinical signs 
Where has the animal been housed, located or pastured for the last 60 days 
Has the animal traveled in the last 60 days 
 If yes, please explain where, for what purpose and for how long 
Is there any known illness in humans that have handled or been around the animal 
If animal is deceased, have any humans examined the carcass 
 If yes, please list name, address, phone contacts  
Any humans necropsied or cut into the carcass? 
 If yes, please list name, address, phone 
Laboratory information 
Name 
Number 
Specimen collection date 
Specimen collected 
Who collected specimen 
 Name, number  
 Was personal protection utilized to collect specimens? 
  If yes, please explain 
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 Was PEP given 
  Date treatment was started 
  If yes, what type, dose, concentration and duration 
Name of test  
Result of test 
Date medical care sought 
 
Symptomatic: 
 Acute death 
 Incomplete rigor mortis 
 Bleeding from orifices- mouth, nose, anus or vulva 
 Fever 
 Depression 
 Lymphadenopathy 
 Swelling of neck/thorax 
 Convulsions 
 Staggering 
 Muscle tremors 
 Excitement 
 Abortion 
 Rapid decrease in milk production 
 Other, please explain 
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Contagious Equine Metritis 
Disease Investigation Guideline 
 
Content:         Version Date: 
Investigation Protocol: 
 Investigation Guideline      09/2013 
Supporting Materials found in attachments: 
 Fact Sheet        09/2013   
 Case Report Form       09/2013 
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CASE DEFINITION  
Clinical Descriptions for Public Health Surveillance: 
Contagious Equine Metritis (CEM) Contagious Equine Metritis (CEM) is a very contagious 
venereal disease of horses caused by Taylorella equigenitalis.  It is primarily spread via an 
infected stallion to mares either through natural breeding or through artificial insemination.  It 
is endemic in some countries, and the causative agent had been eliminated from the United 
States (from 1970’s to 2008). CEM has been reintroduced via contaminated imported animals 
or semen.  The disease effects horses of all breeds but does not affect humans or other animals. 
 
Laboratory Criteria for Case Classification: 
 Definitive:            
o Culture of swabs of the genital tract primarily of the mare. 
o Confirmation utilizing polymerase chain reaction (PCR) 
 Presumptive: 
o A positive test result utilizing identification of specific antibodies- using slide 
agglutination, latex agglutination, direct or indirect immunofluorescence 
o Positive identification of the bacteria on a microscopic examination  
 
Case Classification: 
 Confirmed: A positive result from a cultured test or in a clinical specimen by utilizing 
polymerase chain reaction 
 Probable: A positive on identification of specific antibodies or microscopic evidence of 
the bacteria 
 Suspect: Any horses exhibiting clinical signs consistent with returning to estrus earlier 
than expected, purulent vaginal discharge 10-14 days post breeding or a group of mares 
who experience either of the aforementioned that were bred to the same stallion 
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EPIDEMIOLOGY 
Contagious Equine Metritis (CEM) is not a zoonotic disease, and there is no record of it affecting 
other species.  This disease has worldwide geographic distribution and is most commonly 
carried by asymptomatic stallions. It is then transmitted to mares during natural breeding or 
artificial insemination; it can also be transmitted via contaminated medical equipment (reusing 
speculums and other equipment used for AI). Once a horse tests positive, they will need to 
undergo treatment and quarantine until they become test negative.  This treatment is usually 
one round of treatment in stallion, but can take numerous treatments in infected mares.  The 
organism lives on the external genitalia of stallions and in the reproductive tract of mares.  
 
 DISEASE OVERVIEW 
A. Agent: 
Contagious Equine Metritis (CEM) is caused by the gram negative bacterium, Taylorella 
equigenitalis.   
 
B. Clinical Description: 
Signs include but are not limited to:  
 Stallions: no clinical signs noted 
 Mares: Acute, Chronic, Asymptomatic Carriers 
 Acute: copious amounts of thick white to grey colored vaginal discharge 
10-14 days after breeding 
 Chronic: less vaginal discharge and mild uterine inflammation—this is the 
most common form as well as the most difficult to eliminate 
 Asymptomatic Carrier: post infection, mares can carry bacteria for 
months 
 Although rare: CEM can cause abortions and long term problems with 
fertility  
 
C. Reservoirs: 
CEM affects equines.  It is not transmitted to other species or humans. 
 
D. Mode of Transmission: 
Transmission is venereal through natural breeding or via artificial insemination. CEM can 
also be transmitted by using contaminated equipment during surgeries, or equipment 
used in artificial insemination.  If the mare is able to maintain a pregnancy, she can pass 
CEM to her foal during birth. Asymptomatic stallions carrying the organism easily pass 
this to mares, often undetected until the mare shows clinical signs.  
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E. Incubation Period: 
Variable incubation period, ranging from 3 days to 3 weeks in mares. Often a purulent 
grey to white vaginal discharge will show up after breeding.  Some mares can become 
chronic carriers.  Stallions are often asymptomatic.   
 
F. Period of Communicability: 
Infected stallions can transmit CEM at any point during natural breeding or during 
collection for artificial insemination.  Infected stallions can be asymptomatic for months. 
Mares may also show no clinical signs, but most commonly will have vaginal discharge.  
A large group of mares with vaginal discharge or returning to estrus prematurely that 
were bred by the same stallion need to be evaluated for CEM. Biosecurity and herd 
management are crucial to maintain CEM free animals. 
 
G. Susceptibility and Resistance: 
Susceptibility is determined by herd management, this includes: upkeep, appropriate 
screening and quarantine of newly acquired animals.  
 
H. Treatment: 
Treatment usually consists of physical cleaning of the external genitalia of the stallion 
along with systemic antibiotic therapy.  The mare also requires cleaning of external 
genitals along with systemic antibiotic therapy.  Cleansing needs to happen daily for a 
minimum of five days.  The mare may need continued and repeated antibiotic therapy. 
Additionally, the organism prefers to live in the clitoral sinus of the mare. Special care 
needs to be taken when cleaning this area; if a mare is unable to clear the infection, 
surgical removal of the sinuses may be recommended.  Horses will need to test negative 
for CEM prior to being allowed back into the breeding pool.    
 
I. Vaccine: 
There is no vaccine.   
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NOTIFICATION TO PUBLIC HEALTH AUTHORITIES 
Contagious Equine Metritis CEM infections shall be designated as infectious or contagious in 
their nature, and cases or suspect cases shall be reported within 24 hours: 
 
1. Veterinarians and producers: report to KDA-DAH (see below) 
2. Laboratories: report to KDA-DAH (see below) 
 
Kansas Department of Agriculture – Division of Animal Health (KDA-DAH) 
Phone: 1-785-296-2326 
Fax: 1-785-296-1765 
 
Outbreaks, unusual occurrences of CEM, should be reported WITHIN 7 days by telephone to 1-
877-296-2326.  
 
INVESTIGATOR RESPONSIBILITIES 
1) Use current case definition, to confirm diagnosis. 
2) Conduct a case investigation to identify potential source of infection. 
3) Conduct contact investigation to identify additional cases. 
4) Initiate control and prevention measures to prevent spread of disease. 
5) Complete and report all information requested via the state electronic surveillance system. 
6) As appropriate, use the disease fact sheet to educate individuals or groups. 
STANDARD CASE INVESTIGATION AND CONTROL METHODS 
Case Investigation 
1) Contact the veterinarian who ordered testing of the case and obtain the following 
information.  
 Using the case report form, identify any symptoms of CEM: 
− Record onset date  
− Determine if the onset was acute or insidious 
 Examine the laboratory testing that was done to ensure all testing that could 
confirm the case has been reported in Epi-Trax. 
 Examine and record the therapy that the case received, including any surgeries or 
artificial insemination, if any. 
 Collect case demographic data and contact information (birth date, county, 
sex, addresses for previous year) 
 Record outcomes 
 Collect mingling history from previous year and note any previous contact with positive 
CEM animals or premises previous documented positive 
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2) Investigate epi-links among cases (clusters from same facility, county, herd, farm or 
bloodline, etc…). 
 
 
 
Contact Investigation 
1) Contacts are those with possible exposure to the source of infection.  
2) Examine all potential exposures based on possible sources and potential modes of 
transmission, investigating surrounding farms, fence-lines, co-mingling possibilities (has the 
stallion gotten out), veterinarian case histories (annual exams, artificial inseminations, 
surgeries, etc…) 
 
Case Management  
 Report when negative test result is found. 
 
Contact Management 
1) Other at-risk animals should be quarantined, tested and if positive treated.  Once 
animals are negative they can be allowed back in the herd.   
2) Individuals should test all new animals entering the herd. 
3) Individuals should maintain up-to-date CEM tests on all equines.  
4) Care should be taken to prevent iatrogenic transmission: disinfect or sterilize all surgical 
supplies, artificial insemination equipment and other equipment   
 
Environmental Measures 
1) Maintaining good quality artificial insemination standards 
2) Avoid buying  and introducing untested equines 
 
 
Education 
1) Educate veterinarians about disinfecting equipment to help prevent iatrogenic 
transmission.   
 
MANAGING SPECIAL SITUATIONS 
 
A. Outbreak Investigation: 
There are no formal outbreak definitions; however, the investigator may consider the 
possibility of an outbreak when there is an unusual clustering of cases in time and/or space. 
1) Notify KDA-DAH (785 296 2326) immediately. 
2) Active case finding will be an important part of any investigation. 
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B. Intentional Contamination 
 
Safety Considerations: 
 Risks to public health, health care and emergency response personnel are 
not significant. CEM has not been shown to be a potential bioterrorism weapon. 
Post exposure prophylaxis (PEP): 
 Post exposure prophylaxis is not utilized 
 
Surveillance: 
 Arrange for active surveillance for equines to maintain a CEM free herd; to include: 
monitor for mares not getting pregnant and returning to an early estrus, or have a 
mucopurulent discharge 10-14 days after breeding or either of the previously 
mentioned symptoms occurring in a number of mares all bred by the same stallion.    
 
C. Laboratory Exposure to Contagious Equine Metritis isolates: 
1) Laboratory exposure does not constitute harm at this time  
 
DATA MANAGEMENT AND REPORTING TO THE KDA-DAH  
 
A. Organize and collect data. 
 
B. Report data via the Kansas electronic surveillance system. 
• All essential data that was collected during the investigation, especially data that helps 
to confirm or classify a case. 
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Contagious Equine Metritis (CEM) – Fact Sheet 
 
What is Contagious Equine Metritis? 
Contagious Equine Metritis (CEM) is a very contagious venereal disease of horses caused by 
Taylorella equigenitalis.  It is primarily spread via an infected stallion to mares either through 
natural breeding or through artificial insemination.  It is endemic in some countries; the 
causative agent had been eliminated from the United States, but imported animals or semen 
has periodically re-introduced the disease.  The disease effect horses of all breeds; it does not 
affect humans or other animals. 
How is CEM Transmitted? 
Natural CEM transmission occurs from one infected animal to another animal usually by natural 
breeding.  Mares can be infected by artificial insemination and by fomites (equipment).  
Stallions are the most common source of the infection.   
What are the clinical signs of CEM? 
Stallions generally have no outward clinical signs.  Mares will develop acute inflammation of the 
uterus causing temporary infertility. In some cases the only sign may be an early return to 
estrus during a short cycle. Some mares will develop a white/grey colored vaginal discharge 
post breeding (up to 1-2 weeks).  The discharge is usually grey to white and in complicated 
cases a mixed bacterial infection is present.  Upon examination of the reproductive tract, 
endometritis and vaginitis may be seen.  Most infected mares will not conceive; the rare mares 
that do continue to have a normal pregnancy may give birth to foals that are apparently healthy 
but are carriers of the organism.  Although uncommon, abortions can occur.  Infertility 
generally only lasts a few weeks, but mares can carry the organism for months. The initial 
exposure and infection are typically severe with subsequent infections less severe.  Morbidity is 
high and mortality is low, although economic costs can be very high with loss of breeding, pre-
screening breeding exams, treatment, etc…  
CEM should be suspected if a mare has white/grey vaginal discharge about 2 weeks after 
breeding, or a mare returns to estrus early or if a group of mares bred to the same stallion all 
have similar signs of discharge and/or return to estrus prematurely.  
What is the incubation period for CEM? 
The incubation period is most commonly 2-14 days with infections becoming apparent 10-14 
after breeding.  
How is CEM detected? 
A microscopic exam of the uterine discharge shows a gram-negative coccobacilli and large 
numbers of inflammatory cells.  T. equigenitalis is pleomorphic and will sometimes show 
bipolar staining.  Confirmation is via culture of swabs of the genital tract and/or PCR testing.  
CEM is difficult to grow on culture, thus utilization of a lab familiar (NVSL-National Veterinary 
Services Laboratory) with T. equigenitalis is important.  Additionally, identification can be 
completed with specific antibodies (slide or latex agglutination and direct or indirect 
immunofluorescence).  Stallions may only carry a few of the organisms, indicating that testing 
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needs to be completed on mares.  All CEM testing must be performed at an approved 
laboratory and positive results must be reported to state and federal animal health officials. 
Which equines have to be tested/screened? 
 Equines entering countries that are free of CEM 
 Mares exhibiting clinical signs 
 High risk stallions (first time breeders, exposed to infected premises or mated to 
mare with unknown status) 
What if my equine tests positive for CEM? 
If there is a positive test, CEM can be treated.  A combination of antibiotics and disinfectants is 
usually used.  Stallions often only need a single course of treatment, while mares may take 
months and numerous courses of treatments to completely rid them of infection.  Once a horse 
is test negative for T. equigenitalis they can be used for  breeding again.  The external genitalia 
will need to be cleaned with disinfectants (including chlorhexidine, detergents or sodium 
hypochlorite); in addition, a local antibiotic ointment can be utilized, taking care of the external 
skin and folds (clitoral sinuses) as this is the primary location the organism can be found.  
Removal of the clitoral sinus can also be used as treatment in mares that don’t respond to 
other treatment. Systemic antibiotics are often used in cases. An epidemiological investigation 
will need to be completed to determine cause and location of infection.  
What will happen to animals in close contact with the animal found CEM positive? 
Horses that are found to be positive will need to be quarantined, treated and re-tested.  Upon a 
negative test result the horses can be returned to breeding.  The epidemiologic investigation 
will determine the infected equine’s movement history and identify exposed horses. 
Management practices will be assessed to identify the potential of inadvertent spread by 
humans not handling horses and equipment properly. Any mare considered exposed to a CEM 
positive stallion or contaminated equipment will be quarantined and tested.  
How can I protect my horse from CEM? 
 Obtain a negative CEM test before purchasing a new equine to confirm a negative 
disease status and to reduce the risk of disease entry onto the premises  
 Only purchase horses from geographic areas that are considered CEM free, quarantine 
and re-test animals once on your premise 
 Disinfect or sterilize all equipment, instruments and premises 
This fact sheet is for information only and is not intended for self-diagnosis or as a substitute 
for consultation. 
If you have any questions about the disease described above or think that your animal may 
have an infection, consult with your veterinarian. 
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Contagious Equine Metritis EpiTrax Case Report Template 
Case Report : Contagious Equine Metritis 
Demographics 
Case # 
Investigator- 
 Name 
 Email 
 Phone # 
Veterinarian-  
  Name 
 Address 
 Cell # 
 Work # 
 Email 
 Clinic name 
Owner- 
 Date reported 
 Name 
 Address 
 County 
 Home # 
 Cell # 
 Work # 
 Email 
Animal Demographics 
Species 
Breed 
Gender 
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Age at diagnosis 
State of Origin 
County of Origin 
 
Quarantined 
 If yes, how long? start date of quarantine? 
Is this the first time CEM has been diagnosed on this premises  
Were other equines exposed to the suspect animal 
 If yes, have they been tested for CEM 
  Results and testing protocols utilized 
 If no, were all other equines isolated from the suspect animal 
Exposure History 
How long has the equine been owned by the current owner? 
Where did owner get equine? 
 If previously owned – please provide history of name, address and phone of previous 
owner(s) 
Has the equine ever had a CEM test? 
 If yes, when and where 
 Results? 
Has the mare been artificially insemination? 
 If yes, when and by whom  
 Name and contact information of the stallion used for collection? 
Has the equine had any other medical procedures completed? 
 If yes, what procedures and by whom   
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Where has the equine been housed, located or pastured the last 60 days 
If positive CEM test, has the animal been quarantined? 
Please describe the level of quarantine:  
Has the animal had received treatment? 
 If yes, please explain 
 Medications given: dose, concentration, date 
Is the equine symptomatic: 
• Early estrus 
• Mucopurulent vaginal discharge 
• Other, please explain 
 
Laboratory information 
Name 
Number 
Specimen collection date 
Specimen collected 
Who collected specimen 
 Name, number  
Name of test  
Result of test 
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Equine Infectious Anemia Disease Investigation Guideline 
Equine Infectious Anemia 
Disease Investigation Guideline 
 
Content:         Version Date: 
Investigation Protocol: 
 Investigation Guideline      09/2013 
Supporting Materials found in attachments: 
 Fact Sheet        09/2013   
 Case Report Form       09/2013 
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CASE DEFINITION  
Clinical Descriptions for Public Health Surveillance: 
Equine infectious anemia (EIA) is a retroviral disease of equids that may be characterized by 
acute and/or chronic recurring clinical signs including fever, anemia, edema and weight loss in 
some animals. Many horses have very mild or inapparent signs on first exposure, and carry this 
virus subclinically. The owners of these animals are unlikely to realize that they are infected 
unless serological testing is done. All infected horses, including those that are asymptomatic, 
become carriers and are infectious for life. Infected animals must either be destroyed or remain 
permanently isolated from other equids to prevent transmission. 
Laboratory Criteria for Case Classification: 
 Definitive:            
o Serology is commonly used- agar gel immunodiffusion (AGID) also known as the 
Coggins test. 
o Confirmation utilizing reverse-transcriptase polymerase chain reaction (RT-PCR) 
 Presumptive: 
o A positive test result utilizing the ELISA (enzyme-linked immunosorbent assays 
test.  A confirmatory AGID Coggins test must be completed to confirm status.  
o EIA should be among the differentials in individual horses with weight loss, 
edema and intermittent fever. Also if several horses experience fever, anemia, 
edema, progressive weakness or weight loss, particularly if a new animal has 
been introduced or one of the herdmates has died, EIA should be considered. 
Case Classification: 
 Confirmed: A positive result from a AGID/Coggins test or in a clinical specimen by 
utilizing RT-polymerase chain reaction 
 Probable: A positive on the ELISA test 
 Suspect: Any horses exhibiting clinical signs consistent with weight loss, edema, anemia 
and intermittent fever with a history of a new introductions in the herd or a herdmate 
dying.  
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EPIDEMIOLOGY 
Equine Infectious Anemia (EIA) is not a zoonotic disease, and there is no record of it affecting 
other species.  This disease has worldwide geographic distribution and is most commonly 
carried by asymptomatic horses. EIA can then be transmitted via biting insects, contaminated 
equipment (needles, surgical supplies), milk, semen and sharing bridle bits.  Once a horse is 
infected, they are infectious for life and slaughter or euthanasia is recommended.  If euthanasia 
is not selected, quarantine with specific requirements is mandatory- 200 yards away from other 
equines or a screened-in stall, hot iron or freeze branding and interstate travel is extremely 
restricted.  
 
 DISEASE OVERVIEW 
J. Agent: 
Equine infectious anemia is caused by infectious anemia virus, a lentivirus in the family 
Retroviridae.  
 
K. Clinical Description: 
Signs include but are not limited to: 3 phases of the disease are diagnosed. 
 Acute: severe anemia, hemorrhage, pitting edema, tachypnea, 
tachycardia, petechiae, thrombocytopenia, epistaxis or melena and death 
 Chronic: slow weight loss, mild fever,  edema, anemia, jaundice, 
depression and petechiae on mucus membranes 
o Ophthalmic lesions, characterized by depigmentation with 
prominent choroidal vessels 
 Recurrent: often not recognized, inapparent signs of a “come-and-go” 
mild fever  
o Equines may have episodes of illness divided by periods of health; 
at any point during illness episodes the equine may die. 
Infects equids only; no known human form of the disease. Once a horse is positively 
identified, they are infected for life and can and will transmit the disease.  
 
L. Reservoirs: 
EIA primary effects horses and ponies, but has also been seen in mules.  It is also 
possible in donkeys and zebras or crosses of any of the previous mentioned. It is not 
transmitted to other species. 
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M. Mode of Transmission: 
Transmission is mechanical via the mouthparts of biting insects, most commonly the 
horse fly.  Horses that are experiencing symptoms are more likely to transmit the 
disease as the viremia is at a higher level in the blood.  EIA can also be transmitted by 
using contaminated equipment during surgeries, dental floats or not using new needles 
while injecting or vaccinating horses.  Mares can pass EIA to foals in utero or in milk. The 
virus can also be spread by sharing bridle bits. The virus can also be found in semen, 
although venereal transmission extremely rare. Aerosol transmission is also a possibility 
although not been proven.  
 
N. Incubation Period: 
Variable incubation period, ranging from 1 week to 60 days.  Some horses may remain 
asymptomatic until they are stressed, develop a concurrent illness or are put into 
intense work or exercise.  
 
O. Period of Communicability: 
Infected horses can transmit EIA at any point, but are considered more viremic while 
exhibiting clinical signs.  The sicker the horse the more virus that is traveling in the 
blood. Infected horses can be asymptomatic for years, and only show clinical signs 
during times of stress, illness or heavy work.  Biosecurity and herd management are 
crucial to maintain EIA free animals. 
 
P. Susceptibility and Resistance: 
Susceptibility is determined by herd management, upkeep and appropriate testing and 
quarantine of newly acquired animals.  
 
Q. Treatment: 
There is no known treatment.  Euthanasia is recommended in EIA positive animals. 
Quarantine can be utilized with the following requirements:  1) maintain at least 200 
yards from any other equids, 2) place positive animals in a screened-in stall only (no turn 
out aloud) AND 3) they have to be hot iron or freeze branded based on state 
regulations. 
- Interstate travel of EIA positive horses is EXTREMELY restricted and 
difficult. In the United States most sanctioned events (horse shows, 
rodeos and eventing) require negative Coggins on all participants.     
 
R. Vaccine: 
There is no vaccine or treatment available.   
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NOTIFICATION TO PUBLIC HEALTH AUTHORITIES 
Equine Infectious Anemia EIA infections shall be designated as infectious or contagious in their 
nature, and cases or suspect cases shall be reported within 24 hours: 
 
1. Veterinarians and producers: report to KDA-DAH (see below) 
2. Laboratories: report to KDA-DAH (see below) 
 
Kansas Department of Agriculture – Division of Animal Health (KDA-DAH) 
Phone: 1-785-296-2326 
Fax: 1-785-296-1765 
 
Outbreaks, unusual occurrences of EIA, should be reported WITHIN 7 days by telephone to 1-
877-296-2326.  
 
INVESTIGATOR RESPONSIBILITIES 
1) Use current case definition, to confirm diagnosis. 
2) Conduct a case investigation to identify potential source of infection. 
3) Conduct contact investigation to identify additional cases. 
4) Initiate control and prevention measures to prevent spread of disease. 
5) Complete and report all information requested via the state electronic 
surveillance system. 
6) As appropriate, use the disease fact sheet to educate individuals or groups. 
STANDARD CASE INVESTIGATION AND CONTROL METHODS 
Case Investigation 
1) Contact the veterinarian who ordered testing of the case and obtain the 
following information.  
 Using the case report form, identify any symptoms of EIA: 
− Record onset date  
− Determine if the onset was acute or insidious 
 Examine the laboratory testing that was done to ensure all testing that could 
confirm the case has been reported in Epi-Trax. 
 Examine and record the therapy that the case received, including any vaccinations or 
injections of any sort, surgeries, dental floats, if any. 
 Collect case demographic data and contact information (birth date, county, 
sex, addresses for previous year) 
 Record outcomes: euthanasia or quarantine 
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 Collect mingling history from previous year and note any previous contact with positive 
EIA animals 
3) Investigate epi-links among cases (clusters from same county, herd, farm or bloodline, etc…). 
 
 
 
Contact Investigation 
1) Contacts are those with possible exposure to the source of infection.  
2) Examine all potential exposures based on possible source and potential modes 
of transmission, investigating surrounding herds/farms, fence-lines, co-mingling possibilities, 
veterinarian case histories (annual exams, dental floats, vaccines, surgeries, etc…) 
 
 
Contact Management 
5) Other at-risk animals should be quarantined and tested, and then retested at the 60 day 
quarantine mark prior to allowing back into herd.   
6) Individuals should test all new animals entering the herd. 
7) Individuals should maintain up-to-date Coggins tests on all equids and only attend 
events that require current Coggins tests to enter.  
8) Care should be taken to prevent iatrogenic transmission: use disposable needles and 
syringes only one time; disinfect or sterilize all surgical supplies, dental floats and other 
equipment   
 
Environmental Measures 
3) Maintaining good quality insect control can help to interrupt transmission during an 
outbreak.  
4) Avoid buying  and introducing untested equids  
 
 
Education 
2) Educate veterinarians about disinfecting equipment and utilizing single use needles and 
syringes only one time to help in preventing iatrogenic transmission.   
 
MANAGING SPECIAL SITUATIONS 
 
A. Outbreak Investigation: 
There are no formal outbreak definitions; however, the investigator may consider the 
possibility of an outbreak when there is an unusual clustering of cases in time and/or space. 
1) Notify KDA-DAH (785 296 2326) immediately. 
 
65 
 
Equine Infectious Anemia 
Disease Management and Investigative Guideline 
2) Active case finding will be an important part of any investigation. 
 
B. Intentional Contamination 
 
Safety Considerations: 
 Risks to public health, health care and emergency response personnel are 
not significant. EIA has not been shown to be a potential bioterrorism weapon. 
Post exposure prophylaxis (PEP): 
 Post exposure prophylaxis is not utilized 
 
Surveillance: 
 Arrange for active surveillance for equids to maintain an EIA free herd; to include: 
monitor for low grade fevers, anemia, slow weight loss or any otherwise healthy equine 
that suddenly dies.   
 
C. Laboratory Exposure to equine infectious anemia isolates: 
1) Laboratory exposure does not constitute harm at this time  
 
DATA MANAGEMENT AND REPORTING TO THE KDA-DAH  
 
A. Organize and collect data. 
 
B. Report data via the Kansas electronic surveillance system. 
• All essential data that was collected during the investigation, especially data 
that helps to confirm or classify a case. 
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Equine Infectious Anemia (EIA) – Fact Sheet 
 
What is Equine Infectious Anemia? 
Equine Infectious Anemia (EIA) is potentially fatal blood-borne viral disease that affects all 
equines (i.e. horses, mules and donkeys) worldwide. It is a lentivirus that replicates in red blood 
cells; the destruction of the red blood cells causes anemia.  There are three phases of EIA: 
acute, chronic and recurrent.  Acute phase equines will typically be very sick with anemia and 
often die.  Chronic and recurrent phase equines may or may not look sick or may present with 
mild fever or with slow chronic weight loss. Both clinical and asymptomatic EIA-infected horses 
become carriers of the virus and are infectious for life. There is no effective treatment or 
vaccination for EIA and euthanasia is recommended. The disease does not affect humans or 
other animals. 
How is EIA Transmitted? 
Natural EIA transmission occurs from one infected animal to another animal by biting insects, 
such as horse flies(most common), deer flies and mosquitoes. The virus can also be spread by 
use of contaminated needles, equipment or surgical instruments as well as in milk and semen. 
What are the clinical signs of EIA? 
The clinical signs can very, from an acute infection with slight to high fever for a few days and 
small hemorrhages, to progressive weakness, weight loss, depression and neurological deficits 
(disorientation, stumbling).  Although uncommon, acute, rapid death can be the only clinical 
sign. There is no vaccine or treatment for EIA, and it is often difficult to differentiate from other 
fever-causing diseases (influenza and encephalitis). The most common form of EIA diagnosed is 
the chronic form, in which the horse has repeated fever episodes and develops other clinical 
signs including edema, weight loss, and severe anemia.  
What is the incubation period for EIA? 
The incubation period is most often 1- 3 weeks, but may be as long as 3 months. 
How is the virus detected? 
A serologic test can confirm the diagnosis of EIA. The two most commonly used serologic tests 
are the agar gel immunodiffusion (AGID), commonly known as the Coggins Test, and the 
enzyme-linked immunosorbent assay (ELISA) test. The Coggins test detects the presence of EIA-
specific antibodies in the blood. A positive reading indicates the horse is infected and therefore 
a carrier of the EIA virus. The ELISA test can detect antibodies earlier than the Coggins, but the 
ELISA will more often have false positives, thus a confirmation with the Coggins test is standard 
practice. All EIA testing must be performed at an approved laboratory and positive results must 
be reported to state and federal animal health officials. 
Which equines have to be tested? 
 Equines being entered into exhibitions or competitive events(including shows 
and rodeos) 
 Equines being moved across state lines 
 Equines changing ownership 
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 Equines entering horse auctions or sales 
What if my equine tests positive for EIA? 
If there is a positive test, a veterinarian will quarantine the animal and obtain additional 
samples for confirmatory testing.  If confirmed EIA positive, management options are as 
follows: a) euthanasia, b) lifetime quarantine with permanent isolation a minimum of 200 yards 
from all other horses or c) lifetime confinement in a screened stall. If quarantine is elected, the 
animal will need to be identified by hot iron or freeze branding in accordance with state 
requirements. State of Kansas regulations are managed by the State Livestock Commissioner 
through the Department of Agriculture Division of Animal Health at 1-785-296-2326. As a 
lifetime carrier/reservoir of disease, the movement of an EIA-infected animal is severely 
restricted to prevent the potential for transmission. 
What will happen to animals in close contact with the animal found EIA positive? 
The epidemiologic investigation will determine the infected equine’s movement history and 
identify exposed horses. Management practices will be assessed to identify the potential of 
iatrogenic spread of disease through use of contaminated needles and equipment. Any equine 
considered exposed to an EIA positive horse will be quarantined and tested for EIA. An exposed 
horse that tests negative is retested 60 days after removal of the infected horse from the 
premises to confirm the negative result. Quarantine will remain in effect on exposed horses 
until the 60 day retest results are received and are test negative.  
How can I protect my horse from EIA? 
 Obtain a negative Coggins test before purchasing a new equine to confirm a negative 
disease status and to reduce the risk of disease entry onto the premises  
 Participate only in equine events that require evidence of a negative Coggins test   
 Use disposable needles and syringes for injecting equines and properly dispose of used 
needles/syringes after a single use to prevent needle contamination and disease 
transmission 
 Disinfect or sterilize all equipment or instruments 
This fact sheet is for information only and is not intended for self-diagnosis or as a substitute 
for consultation. 
If you have any questions about the disease described above or think that your animal may 
have an infection, consult with your veterinarian. 
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Equine Infectious Anemia EpiTrax Case Report Template 
Case Report : Equine Infectious Anemia 
Demographics 
Case # 
Investigator- 
 Name 
 Email 
 Phone # 
Veterinarian-  
  Name 
 Address 
 Cell # 
 Work # 
 Email 
 Clinic name 
Owner- 
 Date reported 
 Name 
 Address 
 County 
 Home # 
 Cell # 
 Work # 
 Email 
Animal Demographics 
Species 
Breed 
Gender 
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Age at diagnosis 
State of Origin 
County of Origin 
 
Quarantined 
 If yes, how long? start date of quarantine? 
Is this the first time EIA has been diagnosed on this premises  
Were other equines exposed to the suspect animal 
 If yes, have they been tested for EIA 
  Results and testing protocols utilized 
 If no, were all other equines isolated from the suspect animal 
Exposure History 
How long has the equine been owned by the current owner? 
Where did owner get equine? 
 If previously owned – please provide history of name, address and phone of previous 
owner(s) 
Has the equine ever had a Coggins test? 
 If yes, when and where 
 Results? 
Has the equine been given any injections? 
 If yes, when, by whom and what 
Has the  equine had a dental exam done? 
 If yes, when and by whom 
Has the equine had any other medical procedures completed? 
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 If yes, what procedures and by whom   
Where has the equine been housed, located or pastured the last 60 days 
If positive EIA test, has the animal been quarantined? 
Please describe the level of quarantine: is the equine no closer than 200 yards to other, equines 
or in a screened in stall 
Has the quarantined equine been branded appropriately for identification of being EIA positive? 
Has the equine been sent to slaughter or euthanized 
  Was the equine identified as EIA positive when sent to slaughter 
Is the equine symptomatic 
• Fever  
• Progressive weakness 
•  Chronic weight loss 
• Edema 
• Anemia 
• Acute death 
• Depression 
• Neurological signs 
• Other, please explain 
 
Laboratory information 
Name 
Number 
Specimen collection date 
Specimen collected 
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Who collected specimen 
 Name, number  
Name of test  
Result of test 
 If a PCR test was utilized, was it followed up with an AGID ? 
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Rabies Disease Investigation Guideline 
Rabies 
Disease Management and Investigative Guideline 
CONTENT:          Version Date: 
Investigation Protocol: 
• Investigation Guideline        09/2013 
Supporting Materials (found in attachments): 
• Fact Sheet          09/2013 
• Case Report Form         09/2013 
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CASE DEFINITION (CDC 2011) 
Clinical Description for Public Health Surveillance: 
Rabies is a fatal zoonotic disease found worldwide caused by a Lyssavirus.  All mammals are 
believed to be susceptible and it causes generalized, acute, fatal encephalopathy.  In the United 
States, multiple rabies virus variants are maintained in wild mammalian reservoir populations 
such as raccoons, skunks, foxes, and bats. The United States is declared free of the canine 
variant, but due to the wild population the reintroduction is a risk.  
Rabies virus usually is transmitted from animal-to-animal and animal-to-human through bites as 
the virus is shed in saliva. The incubation period is highly variable and ranges from a few days to 
six months or longer.  Clinical signs include anorexia, dysphagia, cranial nerve deficits, abnormal 
behavior, ataxia, paralysis, altered vocalization, seizures and death. There is no known effective 
treatment for rabies. Clinical signs of rabies in humans are very nonspecific and include general 
malaise, headache and fever. As rabies progresses, neurological dysfunction can be seen: 
agitation, anxiety, confusion, excitation, hallucinations, difficulty swallowing, hypersalivation, 
paralysis and hydrophobia.  Death is within a few days of the onset of symptoms.  
Case Classification:  
Confirmed:  A clinically compatible case that is laboratory confirmed.  
• A positive direct fluorescent antibody test (preferably performed on central nervous 
system tissue), or isolation of rabies virus (in cell culture or in laboratory animal) 
Suspected:  A clinically compatible illness that does not meet the confirmed case definition, but 
with one of the following:  
• Epidemiological link to a documented rabies exposure;  
• Evidence of having interaction with bats; including having a bat in a confined space 
that an individual or animal has also occupied (i.e. house or building) that was not 
previously occupied by a bat 
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LABORATORY ANALYSIS— 
1. Detection of Lyssavirus antigens in a clinical specimen (preferably the brain or the 
nerves surrounding hair follicles in the nape of the neck) by direct fluorescent antibody 
test,  
2. Isolation (in cell culture or in a laboratory animal) of a Lyssavirus from saliva or central 
nervous system tissue 
3. Identification of Lyssavirus specific antibody (i.e. by indirect fluorescent antibody (IFA) 
test or complete rabies virus neutralization at 1:5 dilution) in the CSF 
4. Detection of Lyssavirus viral RNA (using reverse transcriptase-polymerase chain 
reaction [RT-PCR]) in saliva, CSF, or tissue 
A. Animal Testing: 
• Kansas State University (KSU) Rabies Laboratory performs animal testing: there is a 
charge for processing and testing.  
− Prior to preparation and shipping of samples, consult with KSU Rabies 
Laboratory at 785-532-4483 to coordinate sample submission. 
• Animals can only be tested for rabies by euthanizing them.  A fresh cross section of the 
brainstem and cerebellum is required for testing (Obex is preferred specimen). 
− Euthanize in accordance with the American Veterinary Medical Association’s 
Guidelines on Euthanasia. 
− When handling small animals it is preferred that the whole animal is submitted 
for testing. For large animals, send animals head only. 
 
B. Human Samples: 
• The Centers for Disease Control and Prevention (CDC) performs human sample testing 
for both antemortem and postmortem diagnosis.  
• Contact KDHE to coordinate collection and submission of human samples. 
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− Exercise caution when decapitating the animal. Do not damage the brain or 
brain stem or put people at risk of exposure. Appropriate PEP needs to be 
utilized while working on the animal. 
• Packaging and shipping of animal specimens: 
   − Pack the head or small animal in a primary leak-proof container. 
− The primary container is placed into a secondary container with enough cold 
packs to maintain refrigerator temperatures until reaching the lab. 
− The specimen should not be frozen and dry ice is not recommended as it may 
freeze. 
− Samples should be sent to: 
Veterinary Diagnostic Laboratory/RABIES Laboratory 
College of Veterinary Medicine 
Kansas State University – VCS Building 
1800 North Denison Ave. 
Manhattan, KS 66506-5601 
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EPIDEMIOLOGY 
Rabies is present on all continents except for Antarctica, but more than 95% of human deaths 
occur in Asia and Africa. Once symptoms of the disease develop, rabies is nearly always fatal. 
The World Health Organization estimates more than 55,000 people die of rabies every year; 
with 40% being under the age of 15.  In the United States, there are more than 6,000 cases of 
animal rabies reported each year.  Raccoons, skunks and bats are the most frequently 
diagnosed. Dogs are the source of the majority of human rabies deaths. It occurs mainly in 
remote rural communities where measures to prevent dog to human transmission have not 
been implemented in third world countries.  
DISEASE OVERVIEW 
A. Agent: 
Rhabdovirus of the genus Lyssavirus causes rabies.  
B. Clinical Description: 
Rabies virus infects the central nervous system, causing encephalopathy and ultimately death. 
Some animals may die rapidly with minimal clinical signs. In animals, there are three types of 
rabies; 1)encephalitic (furious) rabies where animals are hyperexcitable, hostile, bite, choke and 
hypersalivate, 2) dumb rabies where an animal is timid, shy and depressed and often rejects 
food  3)paralytic – where the animal exhibits lameness and depressed spinal reflexes. Signs of 
animal rabies include: changes in behavior, problems swallowing, hypersalivation, wild animals 
appearing abnormally tame or sick, animals that bite at everything if excited, difficulty moving 
or paralysis, and death. 
Clinical signs of rabies in humans are nonspecific: fever, headache, and general malaise. As the 
disease progresses, neurological symptoms appear: insomnia, anxiety, confusion, slight or 
partial paralysis, excitation, hallucinations, agitation, hypersalivation, difficulty swallowing, and 
hydrophobia with rapid progression to death.   
C. Reservoirs:  
In the United States, raccoons, skunks, foxes, and bats are the major reservoirs. In developing 
countries, dogs remain the main reservoir.  Small rodents and lagomorphs (e.g., squirrels, 
hamsters, guinea pigs, gerbils, chipmunks, rats, mice, wild rabbits) have not been known to 
transmit rabies to humans. 
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D. Mode(s) of Transmission:  
Rabies is spread through the saliva of infected animals via a bite, scratch, or contact with 
mucous membrane or a break in the skin. Skin breaks or mucous membrane exposure to 
nervous tissue (e.g., brain, spinal cord) of an infected animal may also pose a risk of 
transmission.  
E. Incubation Period:  
In animals, the incubation period is general 15-50 days, but can be several months or longer.   
In humans, the incubation period is generally 2 weeks to 2 months, but can be greater than a 
year.  The incubation period may be less if it has been a severe exposure or if the bite is closer 
to the central nervous system, like a bite to the face.   
F. Period of Communicability:  
Dogs, cats, and ferrets have been shown to shed the virus in their saliva up to 10 days before 
the onset of clinical signs and continue to shed throughout the course of disease. Wild animals, 
such as skunks, bats, and foxes, may have virus present in saliva for longer periods before onset 
of clinical symptoms.  
G. Susceptibility and Resistance:  
All mammals are susceptible to rabies.  
H. Treatment:  
Experimental treatment options for humans may be available on a case-by-case basis. However, 
once symptoms occur, the outcome is almost always fatal. 
I. Vaccine:  
Animals:  There are numerous animal rabies vaccines available to be given either yearly or 
every three years; generally starting around 16 weeks of age. Requirements vary by 
country/state/town). 
Humans: There is a human vaccine available for at risk individuals (veterinarians, veterinary 
technicians, animal control officers, parks and wildlife). It needs to be given in a 3 shot 
sequence, with titers checked every other year.  
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NOTIFICATIONS (ANIMAL RABIES) 
The following notifications occur as a result of rabies investigations: 
1. Positive and unsuitable laboratory reports: 
− Kansas State University Rabies Laboratory will notify the submitter of the specimen 
(i.e. veterinarian) KDA and KDHE. 
− The KDHE Epidemiologist-on-call will notify the local health department with 
jurisdiction over the area that the animal was found. 
2. Negative laboratory reports: 
− KSU Rabies Laboratory will notify the submitter of the specimen by fax (i.e. report to 
veterinarian). 
− For unusual circumstances, requests for additional notifications on negative laboratory 
tests may be requested through KDA and KDHE. 
INVESTIGATION GUIDELINES: Veterinarians and livestock inspectors should conduct the 
following steps. 
A. When a positive or unsuitable animal rabies laboratory report (or a verbal account of a 
situation involving a potentially rabid animal) is received: 
1) Identify if any human or other animal exposure occurred with the animal. 
a) Positive lab reports: considered a high risk situation if exposure is identified; 
start PEP and/or begin to manage exposed animals. 
b) Unsuitable reports: investigate as if positive. 
B. If a person was bitten or exposed to animal saliva or brain material:  refer them to the Kansas 
Department of Health and Environment at the following address: 
http://www.kdheks.gov/epi/Investigation_Guidelines/Rabies_Disease_Investigation_Guideline.
pdf 
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C. If an animal was bitten or exposed to animal saliva or brain material: 
1) Assess the risk of rabies transmission to the animal. 
2) Decide on disposition of the exposing animal (source of exposure) and manner how 
exposure occurred. 
3) Recommend quarantine or other disposition of the animal that was potentially 
exposed. 
4) Follow-up to assure compliance with recommendations. 
D. For cases of Human Rabies Identify if there was any human or animal exposure and refer 
them to the Kansas Department of Health and Environment at 
http://www.kdheks.gov/epi/Investigation_Guidelines/Rabies_Disease_Investigation_Guideline.
pdf 
Assess the risk of rabies transmission 
Animal exposures can be classified into three categories, they are: high risk, low risk, and no 
risk. The boundary between these categories is often unclear and a risk assessment is needed 
to decide if the animal was rabid and if post exposure prophylaxis (PEP) or other action is 
needed. 
The risk assessment is based upon the following the following criteria: 
• The type of exposure, as defined above. 
• The risk that the animal is rabid. 
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The risk that an animal is rabid depends on the following circumstances: 
• Is it a species that can be infected with and transmit rabies? 
• Was it possible that the animal had contact with any other species that are known to 
be susceptible to rabies? 
• Is/was the animal exhibiting signs and symptoms of rabies? 
Type of animal causing the exposure: 
Bats: Rabid bats are increasingly implicated as an important wildlife reservoir. Transmission can 
occur from minor unrecognized bites; it is important to make every effort to safely capture and 
test the bat involved in an exposure incident. Bats are considered a high risk exposure and rabid 
unless negative by laboratory tests. 
Wild Animals:  Wild animals are an important rabies reservoir; in Kansas, skunks are most often 
implicated. Clinical signs can be varied, but any animal not acting normally is suggestive of 
rabies.  Vaccinating wild animals has unknown efficacy and is not recommended. Treat any wild 
animal acting strange as rabid, until laboratory proven otherwise.  ` 
 It is illegal to keep skunks, raccoons, foxes, and coyotes as pets (K.A.R. 28-1-14); they 
must be sacrificed and tested.  
 Wild species cross-bred with domestic dogs and cats (owned or not), shall be sacrificed 
immediately and the head submitted for laboratory examination for evidence of rabies 
(K.A.R. 28-1-13 and 28-1-14).  
 Stray or feral dogs, cats, and ferrets are more likely to have had contact with wild 
animals and less likely to have been vaccinated. Treat as wild and regard as rabid unless 
animal tests negative for rabies.  
Livestock: Vaccinated and/or healthy animals are unlikely to be rabid. Livestock exhibiting signs 
of rabies or that died suddenly should be investigated as a suspect rabies case.  
Large rodents (woodchucks and beavers): Large rodents have been found to have rabies in the 
Eastern U.S. where the raccoon-variant rabies virus is circulating. Even though the risk is low, it 
should be evaluated. 
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Small rodents and lagomorphs: Squirrels, chipmunks, rats, mice, hamsters, guinea pigs, gerbils 
and lagomorphs (rabbits and hares) are rarely infected and have not been known to transmit 
rabies to humans.  
Non-mammalian animals: Non-mammals do not transmit rabies.  
Steps for animal that is the source of the exposure:  
 
When investigating a potential rabies exposure of a human or other mammal, the management 
of the animal causing the exposure shall be as follows: 
1. Domestic dog, cat, or ferret that is owned or wanted shall be quarantined 10 days. 
• The 10-day quarantine period begins on day 0, which is the date exposure occurred 
and is completed at the end of day 10. 
• The quarantined animal will be kept in an approved location with allowance to 
maintain follow up during the quarantine period. These may be at the owners’ 
residence, veterinary clinic, or currently licensed shelter.  
• If at any time during quarantine the animal exhibits clinical signs of rabies, it shall be 
humanely euthanized and tested. 
• Healthy animals shall be released to owner at the conclusion of quarantine upon 
payment of any boarding fees.  
2. Stray dogs, cats or ferrets that are healthy can be held for three business days to await claim 
in a facility with a current shelter license. 
• If the stray begins to experience symptoms of rabies, it shall be humanely euthanized 
immediately and tested. 
• For high risk situations due to the severity and/or location of the bite, the holding 
period may be waived in lieu of testing urgency. 
3. Horses, cattle or sheep management shall be determined by the KDA or designee in 
consultation with KDHE. 
4. Other mammals which are known to be involved in rabies transmission shall be humanely 
euthanized immediately and head submitted for testing. 
• This includes hybrids of species known transmit rabies. 
• Any vaccinated mammal if its virus shedding period is unknown. 
5. Small rodents and lagomorphs (squirrels, chipmunks, mice, rats, gerbils, guinea pigs, 
hamsters, rabbits, hares and other species not involved in the transmission of rabies) do not 
need to be sacrificed; unless circumstances, in the judgment of the KDA, indicate otherwise. 
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Post Exposure Protocol if human suspected exposure- please refer to the Kansas Department 
of Health and Environment and CDC for PEP guidelines at: 
http://www.kdheks.gov/epi/Investigation_Guidelines/Rabies_Disease_Investigation_Guideline.
pdf 
 
Note: The 2010 ACIP recommendations for post-exposure prophylaxis do differ from current 
rabies 
vaccine label instructions. Refer to the following: 
http://www.cdc.gov/mmwr/pdf/rr/rr5902.pdf. 
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NOTIFICATION TO PUBLIC HEALTH AUTHORITIES 
All confirmed or suspected rabies cases shall be reported: 
1. Health care providers and hospitals: report to the local public health jurisdiction, KDA-
DAH or KDHE-BEPHI (see below)  
2. Local public health jurisdiction: report to KDA-DAH /KDHE-BEPHI (see below) 
3. Laboratories: report to KDA-DAH or KDHE-BEPHI (see below) 
4. KDA-DAH or KDHE-BEPHI will contact the local public health jurisdiction by. 
Kansas Department of Agriculture-Division of Animal Health (KDA-DAH) 
Phone: 1-785-296-2326 
Fax: 1-785-296-1765 
 
Kansas Department of Health and Environment (KDHE) 
Bureau of Epidemiology and Public Health Informatics (BEPHI) 
Phone: 1-877-427-7317 
Fax: 1-877-427-7318 
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Quarantine or management of EXPOSED animal 
When investigating a potential exposure of rabies to an animal, the following applies: 
1. Determine the rabies immunization status of owned and wanted dogs, cats, ferrets, 
horses, cattle, and sheep. A current vaccination is verified by the owner providing a 
rabies vaccination certificate that contains the following:  
• Positive identification for each mammal showing current vaccination by a 
licensed veterinarian with an approved vaccine for species and 
• Expiration date of the rabies vaccine. 
If the initial vaccination was administered at least 28 days previously or booster 
vaccinations have been administered in accordance with Part III of the 
Compendium of Animal Rabies Prevention and Control 
(http://www.cdc.gov/mmwr/pdf/rr/rr6006.pdf), the animal is considered 
current on vaccination. 
Evaluate overdue booster vaccinations individually (e.g., severity of exposure, 
time elapsed since last vaccination, number of prior vaccinations, current health 
status and local rabies epidemiology). In most cases, overdue animals will not be 
considered current on rabies vaccination. 
There are no USDA licensed biologics for PEP of unvaccinated domestic animals; 
post-vaccination in unvaccinated animals is not considered effective. 
2. Disposition based on animal and vaccination status: 
• The animal shall be quarantined or observed based on vaccination status, type of 
species and ownership status of the animal.  
 
- Observation: exposed animal is kept by the owner as per normal handling procedures in a 
manner that allows the animal to be watched for any changes of behavior or health. 
- Quarantine: exposed animal is kept in a manner that assures the exposed animal is effectively 
restricted from any contact with humans or animals known to contract and transmit rabies. This 
requires that there be no possibility of the animal gaining exit from or another animal gaining 
entry to the quarantine space (including digging under or climbing over fencing) and that there 
is no possibility of contact through spaces in a confining fence by the use of solid fencing 
material or double fence construction with wire mesh. 
•  
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• Any illness in an animal under quarantine or observation should be reported 
immediately to the local health department. If signs suggestive of rabies are present, 
the animal should be euthanized and tested. 
• Owned dogs, cats, ferrets, horses, cattle and sheep that are current with vaccinations 
are immediately re-vaccinated and under the owner’s control for a 45-day observation 
period. 
• Dog, cat, or ferret that is not currently immunized against rabies but is owned or 
wanted and shall be quarantined for six months. 
- Locations of quarantine: residence of the owner, a veterinary hospital, or a 
facility holding a current state pound or shelter license (based upon the owner’s 
ability to comply with quarantine measures) 
- Immunize against rabies one month prior to release from quarantine. 
- Release: healthy animals are released with KDA-DAH or designee’s 
authorization upon payment of a boarding fee. 
• Stray, unclaimed, or unwanted dogs, cats or ferrets shall be humanely euthanized 
immediately. 
• Horses, cattle, and sheep not vaccinated with an approved vaccine shall be sacrificed 
immediately or quarantined for six months under conditions satisfactory to the local 
health officer or designee. The local health officer or designee shall authorize the 
release of the animal upon payment of any boarding fees. 
• Other mammals who are currently vaccinated with an approved vaccine for that 
species shall be revaccinated immediately and quarantined for at least 90 days under 
conditions satisfactory to the local health officer. 
• Other mammals (not vaccinated) shall be sacrificed immediately. Animals maintained 
in USDA-licensed research facilities or accredited zoological parks should be evaluated 
on a case-by-case basis. 
Note: It is not necessary to test animals that are sacrificed as a result of their rabies exposure 
unless the animal is also being investigated as a potential “exposing” animal in a separate 
exposure incident. 
Euthanasia of owned animals 
• When an owner is making arrangements to euthanize a pet for humane reasons, it is 
important to have the owner sign an animal euthanasia consent form. 
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• This form will describe the animal and have the owner attest that to their knowledge it 
has not bitten anyone in the past 10 days. 
− If an animal has bitten someone in the past ten days, the animal must undergo 
post-mortem rabies testing after euthanasia. 
C. Measuring immune response to rabies immunization (in animals) 
• Evidence of circulating rabies virus antibodies cannot be used as a substitute for 
current vaccination in managing a rabies exposure. 
D. Educating the Public 
• Education of the general public is a good measure to prevent exposures. 
• General information can be found on the CDC Rabies website: www.cdc.gov/rabies/ 
− Rabies Exposure: www.cdc.gov/rabies/exposure/index.html 
 
ADDITIONAL INFORMATION / REFERENCES 
 Compendium of Animal Rabies Prevention and Control, 2011 
www.nasphv.org/documentsCompendia.html 
 Centers for Disease Control and Prevention, www.cdc.gov/rabies/ 
 Human Rabies Prevention Recommendations (CDC-ACIP) 
www.cdc.gov/mmwr/preview/mmwrhtml/rr57e507a1.htm 
 Use of a Reduced (4-Dose) Vaccine Schedule for Post exposure Prophylaxis to Prevent 
Human Rabies (CDC-ACIP, 2010) 
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5902a1.htm 
 Information for State Health Departments www.cdc.gov/rabies/statehealthdept.html 
 Kansas State University College of Veterinary Medicine, Rabies Laboratory 
www.vet.ksu.edu/depts/dmp/service/rabies/index.htm 
 Diagnostic Testing and Results for Animals Suspected of Having Rabies: 
www.vet.kstate.edu/depts/dmp/service/rabies/diagnostic.htm 
 Rabies Diagnosis in Animals Submission form 
www.vet.ksu.edu/depts/dmp/service/rabies/pdf/Rabies.pdf 
 World Health Organization www.who.int/health_topics/rabies/en/ 
 American Veterinary Medical Association: 
www.avma.org/public_health/default.asp#rabies 
 www.avma.org/issues/policy/rabies_control.asp 
  
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 A Community Approach to Dog Bite Prevention: 
www.avma.org/public_health/dogbite/dogbite.pdf 
 AVMA Guidelines on Euthanasia: www.avma.org/issues/animal_welfare/euthanasia.pdf 
Animals and Rabies: www.cdc.gov/rabies/exposure/animals/index.html 
Further responsibilities of state and local health departments to the CDC: 
As a nationally notifiable condition, rabies cases require an IMMEDIATE, EXTREMELY URGENT or 
IMMEDIATE, URGENT report to the Center of Disease Control and Prevention (CDC) depending 
on the circumstances. 
INVESTIGATOR RESPONSIBILITIES 
1) Use current case definition, to confirm diagnosis with the Kansas State University Rabies 
Laboratory or veterinarian on the case. 
2) Conduct a case investigation to identify potential source of infection.  
3) Conduct contact investigation to identify additional cases. 
4) Identify whether the source of infection is major public health concern. 
5) Initiate control and prevention measures to prevent spread of disease. 
6) Complete and report all information requested via the state electronic surveillance system. 
7) As appropriate, use the disease fact sheet to educate individuals or groups. 
STANDARD CASE INVESTIGATION AND CONTROL METHODS 
Case Investigation 
1. Contact the veterinarian who ordered testing of the case and obtain the following 
information.  
• Using the Case Report Form, identify any symptoms of rabies: 
− Record earliest onset date, noting the first symptom. 
− Record any other symptoms experienced. 
• Examine the laboratory testing that was done to ensure all testing that could confirm 
the case has been reported in Epi-Trax. 
• Examine and record the therapy that the case received. 
•  
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• Collect case’s demographic data and contact information (birth date, county, sex, 
occupation, address, phone number(s)) 
• Record hospitalizations: location, admission and discharge dates 
• Record outcomes: date of death 
2.  Interview the owner (if one) to determine source and risk factors. 
3.  Investigate epi-links among cases (geographic clusters or contact with similar animals, etc.).  
• For suspected outbreaks go to Managing Special Situations section. 
Contact Investigation- Human Contact 
1) Any human in contact with the source of exposure is defined as a contact. This may include 
physical contact with an infected animal or a contaminated animal specimen.  
• Any exposure that results in a suspected case of rabies requires a public health 
investigation to identify if other exposures in the same setting or geographic location 
might have led to other cases of rabies.  
Contact Management 
1) Symptomatic acquaintances, household members, associates, or co-workers that were also 
potentially exposed should contact their physician for a medical evaluation and are followed-up 
as suspect cases. 
2) Contact Monitoring:  
• Depending on type of exposure, asymptomatic persons who were potentially exposed 
should also see medical care. 
• A medical provider should be consulted immediately if symptoms develop.  
3) Exposure circumstances direct decisions on PEP. Please see “Post Exposure Protocol and 
Schedule” above. 
4) Recommendations may change with additional CDC guidance. 
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MANAGING SPECIAL SITUATIONS 
A. Outbreak Investigation: 
A single case of rabies in the United State is so unusual that it should be reported and 
investigated immediately.  If a cluster of domesticated animals are diagnosed an investigation is 
also warranted to determine cause and vaccination status for control and limit spread to 
humans. 
1) Consider the possibility of an outbreak when there is an unusual clustering of cases in time 
and/or space 
2) Notify KDA-DAH (1-785-296-3556) or KDHE (1-877-427-7317) immediately. 
3) Active case finding will be an important part of any investigation. 
Safety Considerations: 
• Rabies can be transmitted person-to-person (although rare); the infected individual would 
have to bite another human or transmit saliva to another individuals open wound.   
• Greatest risk to human health occurs in locations where dog rabies is prevalent and when 
humans handle or feed wild animals.   
• Response personnel would be at risk if transmission is through a live animal. Necessary 
precautions need to be taken in management and handling of the animal if rabid.   
• Decontamination: Rarely necessary.  
Risk Communication Materials: 
• Factsheet for rabies 
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Diagnosis of Rabies Infection: 
Veterinarians who suspect rabies should take immediate steps for protection of humans by 
instigating quarantine of suspect animals, utilizing appropriate precautions and notify local 
authorities as well as the KDA-DAH.   
 Procedures and guidance on correct methods for acquiring and submitting samples 
should be completed by a licensed veterinarian.  Proper handling of specimen(s) is 
crucial in allowing for accurate testing.   
Treatment: 
Once clinical signs are present, rabies is almost always fatal and no treatment has been shown 
effective.   
DATA MANAGEMENT AND REPORTING TO THE KDA-DAH and KDHE 
A. Organize, collect and report data.  
B. Report data via Epi-Trax. 
• Especially data collected during the investigation that helps to confirm or classify a 
case.  
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Rabies Fact Sheet 
RABIES Fact Sheet 
Rabies is a disease caused by a Lyssavirus from the Rhabdoviridae family that affects the 
nervous system of humans and other mammals. Human rabies is very rare in the United States, 
but most commonly caused by bats. In Kansas, most animal cases of rabies are found in skunks, 
but also can be seen in bats, raccoons and cats. Other mammals including dogs, ferrets, and 
livestock can get rabies if they are not vaccinated. Rabies is rarely reported in rabbits and small 
rodents, such as squirrels, hamsters, guinea pigs, gerbils, chipmunks, rats, and mice.  Rabies is 
present in every state in the United States, except for Hawaii.  
Is Rabies fatal? 
Rabies infections are almost always fatal once symptoms of the disease have started. 
How is rabies spread? 
Rabies virus is found only in the brain, spinal cord, and saliva of animals sick with rabies. The 
rabies virus is most often spread through a bite (that breaks the skin) from an infected animal; 
other ways it is transmitted is via saliva contacting an open wound/scratch or mucous 
membrane (eyes, nose or mouth).  
The following are NOT exposures to rabies: 
 Being scratched by the animal 
 Contact with blood, urine or feces 
 Contact with dried saliva 
 Petting the hair of a rabid animal 
 Touching bowls, equipment (gates/trailers), halters/lead ropes, or other surfaces the 
rabid animal contacted 
How can you tell if an animal is rabid? 
The most common clinical sign is that most rabid animals don’t behave normally.  Wild animals 
may appear friendly or nocturnal animals may be seen during the day.  Animals may stagger, be 
paralyzed, drool, or have seizures. Some normally friendly animals may become very 
aggressive.  In humans, rabies can cause headaches, high fever, confusion, hydrophobia and 
seizures. Rabies will progress to paralysis, coma and almost always death. If an animal is acting 
strange, or has clinical signs suggestive of rabies, stay a safe distance away. If a human or 
another animal is bitten or exposed to the body fluids containing the rabies virus, the only way 
to know whether the animal has rabies is to have it tested. There is no rabies test for live 
animals.  It is important to realize that brain tissue is the specimen and it needs to be 
undamaged. This includes: not shooting the animal in the head or crushing the skull.  Specimens 
need to be refrigerated not frozen until they can be delivered to the laboratory.  
What steps should be taken following an animal bite? 
1. Wash all bite wounds immediately with soap and water, use a disinfectant if available, and 
continue washing for 5-10 minutes. 
2. Contact your health care provider as soon as possible. Animal bite wounds contain bacteria, 
so a tetanus booster and/or antibiotics may be needed. 
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3. If possible, safely catch or restrain the animal. Your local animal control or police may be able 
to help catch the animal; if the animal must be killed, try to do so without damaging the head. If 
the animal has an owner, get contact information (name, address, phone number) and 
information about the animal's rabies vaccination history. 
4. Immediately report the exposure to your local county health agency, health department or 
police.   
5. Treatment should be considered if a bat was present and exposure cannot be ruled out (a 
sleeping person awakens to find a bat in the room or a bat is seen in the room with a previously 
unattended child). 6. Any bats (dead or alive) found in your home should be tested for rabies; 
do not dispose or release any bat without contacting your local animal control.  
What do you do if you suspect rabies? 
The animal bite to human: 
 If a rodent or rabbit caused the bite, these are very low risk and rabies vaccination is 
usually not recommended, but always, check with local animal control or public 
health department. 
 If the biting animal was a dog, cat, or ferret (not owned by the bite victim and not 
currently vaccinated), the animal should be quarantined with a licensed veterinarian 
for ten days. 
 Dogs, cats, and ferrets (not owned by the bite victim and currently vaccinated) may 
be allowed to be quarantined by the animal owner or licensed veterinarian for 10 
days. 
 If the animal dies or is euthanized during the 10 day quarantine, it should be tested 
for rabies. 
 If the dog, cat, or ferret remains healthy after ten days no further action is needed. 
 The local animal control and public health department should be contacted. 
Animals, other than dogs, cats, or ferrets, may need to be quarantined for 30 days 
under the care of a veterinarian, or euthanized and tested depending on the 
exposure and vaccination status. 
The animal bite to another animal: 
 If the animal bitten is owned/wanted but not vaccinated, the animal should be 
quarantined for 6 months by the animal owner or licensed veterinarian and 
vaccinated 1 month prior to conclusion of quarantine period. 
 If the animal bitten has proof of current vaccination, the animal should immediately 
be given a booster vaccine and be quarantined for 45 days by the animal owner or 
licensed veterinarian.  
When do you need treatment? 
People bitten by an animal that tests positive for rabies should always receive the post 
exposure prophylaxis (PEP). PEP generally consists of four doses of rabies vaccine and rabies 
immune globulin (RIG), usually given at the same time as the first vaccine dose.  An individual 
may also want to receive pre-exposure rabies vaccines; these individuals would be inclined to 
have frequent contact with potentially rabid animals or be traveling to a location (foreign 
country) where dog rabies is common.  
How long after exposure will the first symptoms start? 
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The time interval between the exposure to the rabies virus and onset of clinical signs is variable.  
In animals the time interval is generally between 3-8 weeks, but can be as long as six months; in 
humans, the interval is usually 4-12 weeks after exposure.   
How can rabies be prevented? 
 Be a responsible pet owner! Make sure all pets are current on their rabies 
vaccinations, this includes horses and other livestock.  
 Keep dogs and cats close to home, they should not be allowed to roam freely.  
 If your pet comes into contact with a skunk or bat, contact your veterinarian as soon 
as possible. Keep the animal away from other animals and people and wear gloves 
while handling it.  
 Do not handle or feed wild animals and do not keep them as pets. If you see an 
injured wild animal, contact the nearest animal control agency or wildlife 
rehabilitation facility for assistance.  
 Teach children to avoid contact with any wild animals or animals that are unfamiliar 
to them. 
 Do not leave pet food outdoors for long periods of time, keep trash cans tightly 
sealed and keep brush piles cleared away from buildings to help discourage wild 
animals from being around your house. 
 Try to prevent bats from having access inside your home, use screens and chimney 
caps and remember, whether alive or dead, they should be tested for rabies. 
This fact sheet is for information only and is not intended for self-diagnosis or as a substitute 
for consultation. If you have any questions about the disease described above or think that your 
animal may have an infection, consult with your veterinarian. 
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Appendix D-3 
Rabies Case Report Template 
Case Report Rabies 
Demographics 
Case # 
Investigator- 
 Name 
 Email 
 Phone # 
Veterinarian-  
 Name 
 Address 
 Cell # 
 Work # 
 Email 
 Clinic name 
Owner- 
 Date reported 
 Name 
 Address 
 County 
 DOB 
 Home # 
 Cell # 
 Work # 
 Email 
 
Whomever was bitten or exposed- 
 Has the individual previously received the vaccine series?  When? 
 When were the titers last checked and what were they? 
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 Has the individual had a tetanus vaccine within the last five years? 
Any other humans in contact with suspect animal? 
 Name 
 Address 
 Phone 
 Date of contact with suspected animal 
 Type of contact 
 
Animal Demographics 
Species 
Breed 
Gender 
State of Origin 
Age at disease onset 
Quarantined 
Deceased 
Was animal euthanized- 
 If yes, method of euthanasia used 
 Carcass disposal? 
  How, when, where 
Were other animals exposed to the suspect animal 
 If yes, are they sick or showing the same clinical signs or dead 
 If no, were they isolated from the suspect animal 
What is the vaccination status of the exposing animal?  
 What is the vaccination history? 
97 
 
 Were the vaccines administered by a licensed veterinarian?  
If the suspect animal bit another animal, what is the vaccine status of the animal that was 
bitten? 
  
Exposure History 
How long has the animal been owned by the current owner? 
Was the owner bitten or in contact with the saliva of the suspect animal? 
Was anyone else bitten by or in contact with the saliva of the suspect animal? 
If a human was bitten, what was the anatomical site bitten (i.e. hand, arm, leg, face, etc..)? 
What were the circumstances surrounding the bite? Please be specific; certain instances 
animals may be more inclined to bite- things like protecting its food or surroundings, or if an 
animal was hit by a car—please explain the events that led up to the bite. 
Where did owner get animal? 
Other animals that are in contact with currently sick or dead animal? Please describe 
 If yes, what species, how many, type of contact 
Has the animal been exposed to wild life or other rabies vectors? 
Has the animal traveled in the last 60 days 
 If yes, please explain where, for what purpose and for how long 
For the animal causing the exposure (or animal that completed the bite) Actions taken: 
___ Dog, cat or ferret quarantined for 10 days. (Start date: ___________ End date: ________ ) 
Location of quarantine:_______________________________________________________ 
Animal euthanized and tested for rabies. (Test result: _____________________________) 
Other(please explain):___________________________________________________________ 
For the animal exposed (or animal that was bitten) Actions taken: 
___ Animal was euthanized. Date _________ 
___ Animal was revaccinated and quarantined for 45 days (previously vaccinated animal) 
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Location of quarantine:________________________________________________________ 
Animal was quarantined for 6 months then vaccinated 1 month prior to release (non-vaccinated 
animal) 
Location of quarantine:__________________________________________________________ 
Laboratory information 
Name 
Number 
Specimen collection date 
Specimen collected 
Who collected specimen 
 Name, number  
 Was personal protection utilized to collect specimens? 
  If yes, please explain 
 Was PEP given 
  If yes, what type, dose, concentration and duration 
Name of test  
Result of test 
Symptomatic 
 Acute death 
 Hyperexcitable 
 Aggressive 
 Hypersalivation 
 Choke/problems swallowing 
 Depressed 
 Anorexic 
 Lameness 
 Not acting normal for that animal (i.e. friendly animal  becomes very aggressive, or a 
wild animal is suddenly not fearful of humans) 
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 Unexplained behavior changes 
 Paralysis 
 Hydrophobia 
 Other, please explain 
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Bovine Trichomoniasis 
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Trichomoniasis 
Disease Management and Investigative Guideline 
CASE DEFINITION  
Clinical Descriptions for Public Health Surveillance: 
 A venereal disease of cattle caused by a flagellated protozoan parasite, Tritrichomonas 
foetus (Trich), transmitted by infected, usually asymptomatic bulls to heifers or cows 
during mating.  Clinical signs are early pregnancy loss (peak loss is at 70-90 days 
gestation) and low pregnancy rates that can progress through different herds within the 
same farm.   Other signs include one or more of the following: pyometra, abortion and 
retained fetal membrane. Generally bulls will be asymptomatic carriers, but can have a 
small amount of purulent discharge during the first two weeks of infection.  
Laboratory Criteria for Case Classification: 
 Definitive:            
o KDA-DAH recommends identification via polymerase chain reaction (PCR)  
o Additional confirmation via culture and identification of T. foetus from clinical 
specimens; utilizing InPouch TF (Biomed Diagnostics) Gold standard: 6 weekly 
samples and production standard is 3 weekly samples with not mating in 
between samples.  
 Presumptive: 
o The flagellated parasites can be identified by direct microscopic examination of 
collected fluids (vaginal, preputial secretions, amniotic, allantois or abomasal 
fluids). 
o Samples can be inoculated into media (commonly Diamonds’ or Claussen’s 
media) and allowed to grow in vitro until adequate numbers of parasites are 
present 
Case Classification: 
 Confirmed: A clinically compatible illness with definitive laboratory evidence of T. foetus 
infection/ isolation of T. foetus from a clinical specimen by culture or in a clinical 
specimen by utilizing polymerase chain reaction 
 Probable: A clinically compatible case and evidence of the flagellated parasite on 
microscopic exam of collected fluids or post in vitro growth in an appropriate media 
 Suspect: A clinically compatible case that is epidemiologically linked to a confirmed 
case. 
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EPIDEMIOLOGY 
Bovine Trichomoniasis  (Trich) is not a zoonotic disease, but there is a human strain that is 
unrelated to the bovine strain.  This disease has worldwide geographic distribution and is most 
commonly carried by asymptomatic bulls.  These bulls upon mating will infect cows and heifers.  
Often cows and heifers will clear the infection in a few months, but some can remain infected 
through pregnancy and infect bulls in the next season.  The cows and heifers do not have long 
lasting immunity and may become re-infected after clearing the infection.  Only bulls less than 3 
years old may clear infection, but bulls older than 3 will remain infected for life; this is primarily 
due to the depth of the epithelial crypts of the penis and prepuice.  It is more commonly seen in 
larger herds and where commingle grazing is common.  
DISEASE OVERVIEW 
S. Agent: 
T. foetus is caused by a parasite with 3 anterior and 1 posterior flagellum, is pyriform in 
shape, and has an undulating membrane causing characteristic rolling and jerking 
movement. Time, temperature and type of medium that specimens are maintained in 
can decrease sensitivity of tests used in diagnosis.  
 
T. Clinical Description: 
Signs include but are not limited to: cows/heifers – early fetal loss, abortion, lower birth 
weight, pyometra and low fertility rates; in bulls- often asymptomatic, may have 
purulent discharge during the first two week post infection.  Cow/heifers and young 
bulls (under 3 years of age) will generally clear the infection in weeks to months.  Bulls 
over the age of 3 are chronically infected.  
 
U. Reservoirs: 
T. foetus primarily affects cattle, but has been shown to be a cause of diarrhea in cats.  
Other strains can infect pigs, birds and humans. 
 
V. Mode of Transmission: 
Transmission occurs through direct contact with infected animals’ fluids and/or tissues 
during natural mating.  Artificial insemination is recommended only if appropriate 
sanitation and methods are maintained.  
 
W. Incubation Period: 
Variable incubation period, ranging from 30 minutes to 95 days but may be several 
months; most commonly will find open cows in a herd (between 120-150 days 
gestation). 
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X. Period of Communicability: 
Infected Bulls over the age of 3 are considered chronically infected and should be sent 
to slaughter.  Infected cows/heifers can transmit T. foetus to bulls during mating, thus 
resulting in a bull (if they are over 3 yrs) that can then be considered chronically 
infected. Biosecurity and herd management are crucial to maintain T. foetus free 
animals. 
 
Y. Susceptibility and Resistance: 
Susceptibility is determined by herd management, upkeep and appropriate testing and 
quarantine of newly acquired animals.  
 
Z. Treatment: 
There is no known treatment.  In bulls over the age of 3 and cows/heifers that are open 
after 120 days of gestation, culling is recommended.    
 
AA. Vaccine: 
There is a vaccine that can be utilized in high risk herds with one vaccine given 2 months 
prior to the breeding season and then boostered 2-4 weeks later (for cows/heifers only).  
The vaccine has not been shown efficacious in bulls. This vaccine does not prevent 
disease but has been shown to reduce the incidence of early fetal loss and abortion. 
NOTIFICATION TO PUBLIC HEALTH AUTHORITIES 
T. foetus infections shall be designated as infectious or contagious in their nature, and cases or 
suspect cases shall be reported within seven days: 
 
1. Veterinarians and producers: report to KDA-DAH (see below) 
2. Laboratories: report to KDA-DAH (see below) 
 
Kansas Department of Agriculture – Division of Animal Health (KDA-DAH) 
Phone: 1-785-296-2326 
Fax: 1-785-296-1765 
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Outbreaks, unusual occurrences of trich, should be reported WITHIN 7 days by telephone to 1-
785-296-2326.  
 
INVESTIGATOR RESPONSIBILITIES 
1) Use current case definition, to confirm diagnosis. 
2) Conduct a case investigation to identify potential source of infection. 
3) Conduct contact investigation to identify additional cases. 
4) Initiate control and prevention measures to prevent spread of disease. 
5) Complete and report all information requested via the state electronic 
surveillance system. 
6) As appropriate, use the disease fact sheet to educate individuals or groups. 
STANDARD CASE INVESTIGATION AND CONTROL METHODS 
Case Investigation 
1) Contact the veterinarian who ordered testing of the case and obtain the 
following information.  
 Using the case report form, identify any symptoms of Trich: 
− Record onset date (if a reoccurrence – record the earliest onset date) 
− Determine if the onset was acute or insidious 
 Examine the laboratory testing that was done to ensure all testing that could 
confirm the case has been reported in Epi-Trax. 
 Examine and record the therapy that the case received, including vaccinations, if any. 
 Collect case demographic data and contact information (birth date, county, 
sex, addresses for previous 2 years) 
 Record outcomes: recovered or date of culling 
 Collect breeding history from previous two years and note any previous contact with 
positive Trich animals 
3) Investigate epi-links among cases (clusters from same county, herd, farm or bloodline, etc…). 
 
Contact Investigation 
1) Contacts are those with possible exposure to the source of infection.  
2) Examine all potential exposures based on possible source and potential modes 
of transmission, investigating surrounding herds/farms, fence-lines, co-mingling possibilities, 
history of breeding activities or livestock sales 
 
Contact Management 
9) Other at-risk animals should be tested, weekly for a minimum of three weeks if using 
the InPouch TF system or a single PCR test to monitor for any disease.  
10) Individuals should try to utilize young breeding bulls or buy only virgin bulls and heifers.  
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11) Implementation of a very defined breeding season is important in determining 
pregnancy dates and gestational length to assist in ruling out Trich.  
12) Consider keeping bulls in the same breeding groups for numerous breeding seasons. 
13) Possibly utilize artificial insemination to help prevent introduction of Trich or to help 
break the cycle of infection. 
 
 
Environmental Measures 
5) Maintenance of good perimeter fencing to segregate cattle of unknown status is the 
first line of defense to prevent Trich from entering a herd. 
6) If biosecurity measures cannot be maintained or there are other risk factors, vaccination 
of cows can help in mitigating economic losses. 
7) Avoid buying open cows- meaning less than 120 days. If these animals are purchased 
they must be quarantined and examined prior to joining  the herd. 
 
 
Education 
3) Educate veterinarians about sample collection- understand that temperature, 
methodology of sample collection and submission time can all affect test results. 
 
MANAGING SPECIAL SITUATIONS 
 
A. Outbreak Investigation: 
There are no formal outbreak definitions; however, the investigator may consider the 
possibility of an outbreak when there is an unusual clustering of cases in time and/or space. 
1) Notify KDA-DAH (785-296-3556) immediately. 
2) Active case finding will be an important part of any investigation. 
 
B. Intentional Contamination 
 
Safety Considerations: 
 Risks to public health, health care and emergency response personnel are 
not significant. T. foetus has not been shown to be a potential bioterrorism weapon. 
Post exposure prophylaxis (PEP): 
 Post exposure prophylaxis is not utilized 
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Surveillance: 
 Arrange for active surveillance for cows/heifers and young bulls to maintain a Trich free 
herd; to include: monitor for low fertility rates, abortion, pyometras among females and 
consistent testing of bulls.  
 
C. Laboratory Exposure to T. foetus isolates: 
1) Laboratory exposure does not constitute harm at this time  
 
DATA MANAGEMENT AND REPORTING TO THE KDA-DAH  
 
A. Organize and collect data. 
 
B. Report data via the Kansas electronic surveillance system. 
• All essential data that was collected during the investigation, especially data 
that helps to confirm or classify a case. 
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Appendix E-2 
Trichomoniasis Fact Sheet 
 
Bovine Trichomoniasis “Trich” Fact Sheet 
What is Trich?  
Trichomoniasis, commonly referred to as “Trich,” is a highly contagious venereal disease in 
cattle caused by a microscopic protozoan parasite, Tritrichomonas foetus, that can result in 
abortions and infertility. In the cow, the organism lives in the vagina and uterus; while in bulls, 
the organism lives in microscopic folds, or crypts, on the skin of the penis and prepuce. As a bull 
ages, conditions on the surface of the penis are more conducive for this protozoa to survive and 
multiply. It is transmitted from infected bulls to heifers or cows at the time of breeding. It is not 
a human health issue, although there is another strain of trichomoniasis only found in humans.  
 
Clinical Signs 
An infected bull often has virtually no outward signs of infection, even though he is the main 
source of infection in a herd.  Once bulls, that are over the age of 3, are infected, they are 
considered infected for life and culling is recommended.  Bulls that are under the age of 3 can 
clear the infection, but close monitoring and testing needs to be established in order to utilize 
these animals as breeders.  An infected cow may have very subtle signs; she may have mild 
vaginal discharge for 1-3 weeks post infection, but in most cases no outward signs are 
apparent.  Most commonly you will see open cows late in the season. These cows will often 
clear the infection within 120-150 days. They do not develop immunity to the disease and can 
therefore be re-infected the next breeding season.  Some cows can remain chronically infected 
and still be able to deliver a normal calf; this is very rare, and these cows can continue to be the 
source of infection to bulls in the next breeding season. 
 
Diagnosis and Why is it Important? 
The economic loss to the cattle producer is multifactorial, including lower fertility, lower birth 
and weaning weights, reduced calf crop with early and some late term abortions. The only way 
to confirm trich infections is through testing at a certified laboratory.  The organism is most 
readily identified in bulls since they are more likely to become long-term carriers of the disease; 
whereas cows can often eventually clear the infection.  A preputial scraping sample is taken 
from the bull and stored in special media.  This sample can be used for two different types of 
tests: either a PCR (polymerase chain reaction) or culture to identify the parasite.  If culture is 
used, three sequential tests are required at weekly intervals with no exposure to cows or 
heifers during the testing timeframe.  A negative trich test is valid for 60 days (?) or until a bull 
mingles with female cattle, whichever comes first.  
 
Control and Prevention  
No treatment is available for bovine trich, which makes identifying infected bulls well before 
breeding season vital.  The most effective way to control trich is to prevent the introduction of 
it into a herd.  Some of the best ways to accomplish this are as follows: 
 Test all new bulls prior to allowing them contact with your current herd 
 Preventing unwanted bulls access to your property through damaged fences 
 Keeping a younger breeding bull battery and purchase virgin bulls when possible 
 Establish a defined breeding season with early pregnancy diagnosis and culling open 
cows 
 Purchase cows/heifers from reputable sources 
 Maintaining good biosecurity of your herd and facility 
 Slaughter of infected bulls  
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A vaccine is available to aid in the control of this disease. The vaccine can be useful in cows but 
does not protect bulls from becoming infected. Vaccination requires two injections, typically 
administered 2 to 4 weeks apart with the second dose no earlier than 30 days prior to the start 
of the breeding season. Consult with your veterinarian when starting a trich vaccination 
program for your herd. 
Shipment Regulations 
Cattle producers should be aware of the trich testing requirements for the destination states 
prior to moving cattle. For the state of Kansas you can find the regulations at: (web address) 
Exceptions are: 
 Bulls less than 19 months of age that can be certified as virgin bulls 
 Bulls consigned directly to slaughter 
 Rodeo or eventing animals that travel to the event and then leave the state 
This fact sheet is for information only and is not intended for self-diagnosis or as a substitute 
for consultation. If you have any questions about the disease described above or think that your 
animal may have an infection, consult with your veterinarian. 
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Trichomoniasis Case Report Template 
Case Report : Trichomoniasis 
Demographics 
Case # 
Investigator- 
 Name 
 Email 
 Phone # 
Veterinarian-  
  Name 
 Address 
 Cell # 
 Work # 
 Email 
 Clinic name 
Owner- 
 Date reported 
 Name 
 Address 
 County 
 Home # 
 Cell # 
 Work # 
 Email 
Animal Demographics 
Species 
Breed 
Gender 
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Age at diagnosis 
State of Origin 
County of Origin 
 
Quarantined 
 If yes, how long? start date of quarantine? 
Is this the first time Trich has been diagnosed on this premises  
Were other animals exposed to the suspect animal 
 If yes, have they been tested for Trich 
  Results and testing protocols utilized 
 If no, were all other animals isolated from the suspect animal 
Exposure History 
How long has the animal been owned by the current owner? 
Where did owner get animal? 
 If previously owned – please provide history of name, address and phone of previous 
owner(s) 
If a bull, has current owner used for breeding in the last 60 days? 
 If yes, natural service or AI 
  If it was AI, where was semen shipped or used 
 If natural service, was the bull only used with current owners cows/heifers 
   -approximate number of cows/heifers exposed 
   - any of the exposed cows/heifers been tested for Trich 
    Results and testing protocols utilized 
  If bull was loan or leased, to whom, where and when 
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   -approximate number of cows/heifers exposed 
   - any of the exposed cows/heifers been tested for Trich 
    Results and testing protocols utilized 
Has the bull gotten out in the last 60 days? 
Where has the animal been housed, located or pastured the last 60 days 
If three cultures were performed at weekly intervals, was the bull kept away from cows/heifers 
during this time frame 
Was bull kept away from cows/heifers for 14 days prior to initial (or first) test 
Was the animal on any medications at the time of testing 
 If yes, name, dose, concentration, duration 
At a positive diagnosis, was the animal treated 
 If yes, treatment type, dose, concentration and duration 
 Currently being treated 
 Has the animal been vaccinated for trich 
 Has the animal been sent to slaughter 
  Was the animal identified as Trich positive when sent to slaughter 
Is the animal symptomatic 
• Preputial swelling  
• Purulent discharge from penis 
•  Increased number of cows/heifers open after 120-150 days of gestation 
• Low grade fever 
• Pyometra 
• Abortion 
• Retained fetal membranes 
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• Low fertility rates in a herd 
• Other, please explain 
 
Laboratory information 
Name 
Number 
Specimen collection date 
Specimen collected 
Who collected specimen 
 Name, number  
How was specimen collected- please be very specific  
 Was specimen kept in an incubator or warmed 
 How long between sample collect and submission 
Name of test  
Result of test 
 Organism name 
 Organism species 
 Organism serotype or serogroup (if known) 
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Vesicular Exanthema Disease Investigation Guideline 
Vesicular Exanthema 
Disease Management and Investigative Guideline 
CONTENT:          Version Date: 
Investigation Protocol: 
• Investigation Guideline        10/2013 
Supporting Materials (found in attachments): 
• Fact Sheet          10/2013 
• Case Report Form         10/2013 
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CASE DEFINITION  
Clinical Description for Public Health Surveillance: 
Vesicular exanthema is a highly infectious viral disease of swine characterized by fevers and 
vesicles on the mouth, snout, coronary band and soles of the feet. These vesicles swell and 
break, leaving very painful open sores.  These animals will often go off feed and water, suffer 
mild-to-severe weight loss, and may show signs of lameness.  It mainly affects swine (rarely 
horses) and sea mammals; it has not shown to be infective to other species.  It also closely 
mimics three other vesicular diseases (foot-and-mouth disease, swine vesicular disease, 
vesicular stomatitis). The only method to differentiate between these diseases is through 
laboratory tests. The geographic distribution is variable depending on the outbreak, but 
vesicular exanthema was in the United States in the 1950’s but intense monitoring and 
surveillance has led to the disease being eradicated.  The United States is currently declared 
disease free.  
Because of the similarity of vesicular exanthema to both vesicular stomatitis and to foot-and-
mouth disease, the potential negative impact on livestock production, and its public health 
implications, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection 
Service (APHIS) works to keep this disease from becoming established in the United States. 
Vesicular exanthema is recognized internationally as a reportable disease, and exports of swine 
and animal products from the U.S. would be restricted if vesicular exanthema were allowed to 
spread here. 
Case Classification:  
Confirmed:  A clinically compatible case that is laboratory confirmed.  
• A positive ELISA, complement fixation, virus neutralization or confirmed in culture by 
immunofluorescence test. 
Reverse Transcriptase Polymerase Chain Reaction RT-PCR can also be used.   
Suspected:  A clinically compatible illness that does not meet the confirmed case definition, but 
with one of the following:  
• Epidemiological link to a documented vesicular exanthema exposure;  
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• Evidence of having interaction with animal saliva or fluid from vesicles and exhibiting 
clinical signs 
LABORATORY ANALYSIS— 
1. Detection of the vesicular exanthema virus in a clinical specimen (preferably the 
vesicular fluid, epithelial tags from the lesions, or swabs from the lesions); there are 
three commonly used serologic tests 1)ELISA, virus neutralization 2)complement fixation 
and 3) PCR test.  
2. Isolation (in cell culture or in a laboratory animal) 
Animal Testing: 
• Please contact the laboratory prior to sending in samples.  It is important to handle 
samples carefully and accurately.  
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EPIDEMIOLOGY 
Vesicular exanthema is a highly infectious viral disease of swine characterized by fevers and 
vesicles on the mouth, snout, coronary band and soles of the feet. These vesicles swell and 
break, leaving very painful open sores.  These animals will often go off feed and water, suffer 
mild-to-severe weight loss, and may show signs of lameness.  It mainly affects swine (rarely 
horses) and sea mammals; it has not shown to be infective to other species.  It also closely 
mimics three other vesicular diseases (foot-and-mouth disease, swine vesicular disease, 
vesicular stomatitis). The only method to differentiate between these diseases is through 
laboratory tests. The geographic distribution is variable depending on the outbreak, but 
vesicular exanthema was in the United States in the 1950’s but intense monitoring and 
surveillance has led to the disease being eradicated.  The United States is declared disease free.  
It originally appeared in California in 1932 in pigs found to be fed raw garbage; at that time 
these animals were thought to have foot-and-mouth disease, were subsequently euthanized, 
burned and buried. It reappeared in 1933 and 1934 and it was determined that the cause was, 
in fact, not foot-and –mouth disease or vesicular stomatitis, but was named vesicular 
exanthema.  It appeared again in a severe outbreak in 1939 and was found in a processing plant 
in 1952 in Nebraska (first time being detected outside California)- but was traced back to raw 
garbage originating in California. These hogs were shipped out of the plant and within a month 
vesicular exanthema had been detected in 18 states.  A state of emergency was declared and a 
federal quarantine was implemented.   
 
DISEASE OVERVIEW 
A. Agent: 
 The viruses are members of the family Caliciviridae and genus Vesiculovirus. They are bullet 
shaped and composed of a single strand of RNA.   
 
B. Clinical Description: 
Generally there will be a fever, but often this isn’t seen by the time the animal is observed and 
examined by a veterinarian.  Vesicles and erosions around the snout, mouth, coronary band  
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and feet are generally the first clinical sign.  Lameness and anorexia quickly follow with total 
reluctance to move also possible.  Hypersalivation is often seen.  Ulcers and erosions on the 
teats are not uncommon and may result in secondary cases of mastitis. It is generally self-
limiting with resolution usually happening within 2 weeks. If the lesions are extremely severe 
on the coronary band and foot, the hoof may slough and regrowth in pigs can take up to 6 
months. Neutralizing antibodies persist, and these swine may continue to be undetected 
carriers of the disease.   
C. Reservoirs:  
The main reservoir is other swine.  It can go undetected in swine that have recovered from the 
disease.    
D. Mode(s) of Transmission:  
Vesicular exanthema spread is not well understood, however, there are believed to be three 
main modes of transmission.  The first is swine that are fed raw garbage(contains pork scraps) 
have a dramatic increase in likelihood of contraction of disease. It can be spread swine to swine 
from close contact.  The fluid within the vesicle is highly infective of the virus and can be 
transmitted to pigs that have come into contact with an infected pig.  The third mode of 
transmission is via humans carrying the virus on their clothing, shoes or equipment.     
E. Incubation Period:  
In general, the incubation period is generally 24 to 72 hours.   
F. Period of Communicability:  
Animals have been shown to shed the virus in their saliva and from the fluid in the vesicles as 
they rupture; once these vesicles are healed they generally are not as infective.  Humans need 
to utilize proper biosecurity and cleaning protocols.  Swine that have recovered from the virus 
can become inapparent carriers and their bodily secretions can spread the virus.  
G. Susceptibility and Resistance:  
Swine, sea lions, other sea mammals and horses are susceptible to vesicular exanthema; 
morbidity is very high and mortality is low.  
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H. Treatment:  
Treatment consists of supportive care, usually antibiotics are prescribed with secondary 
infections.  The lesions are extremely painful and thus pain control medications are  
often added.  In addition, some animals will need to be given soft or wet food to aid in ease of 
mastication.  Antiseptic cleaning of the open wounds can also promote healing. 
I. Vaccine:  
There is no vaccine available in the United States.  
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NOTIFICATION TO PUBLIC HEALTH AUTHORITIES 
Vesicular exanthema infections shall be designated as infectious or contagious in their nature, 
and cases or suspect cases shall be reported within 24 hours: 
 
1. Veterinarians and producers: report to KDA-DAH (see below) 
2. Laboratories: report to KDA-DAH (see below) 
 
Kansas Department of Agriculture – Division of Animal Health (KDA-DAH) 
Phone: 1-785-296-2326 
Fax: 1-785-296-1765 
 
Outbreaks, unusual occurrences of VE, should be reported WITHIN 7 days by telephone to 1-
785-296-2326.  
 
INVESTIGATOR RESPONSIBILITIES 
1) Use current case definition, to confirm diagnosis. 
2) Conduct a case investigation to identify potential source of infection. 
3) Conduct contact investigation to identify additional cases. 
4) Initiate control and prevention measures to prevent spread of disease. 
5) Complete and report all information requested via the state electronic surveillance system. 
6) As appropriate, use the disease fact sheet to educate individuals or groups. 
STANDARD CASE INVESTIGATION AND CONTROL METHODS 
Case Investigation 
1) Contact the veterinarian who ordered testing of the case and obtain the following 
information.  
 Using the case report form, identify any symptoms of VE: 
− Record onset date  
− Determine if the onset was acute or insidious 
 Examine the laboratory testing that was done to ensure all testing that could 
confirm the case has been reported in Epi-Trax. 
 Examine and record the therapy that the case received. 
 Collect case demographic data and contact information (birth date, county, 
sex, addresses for previous year) 
 Record outcomes 
 Collect mingling history from previous year and note any previous contact with positive 
VE animals or premises previous documented positive 
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2) Investigate epi-links among cases (clusters from same facility, county, herd, farm or 
bloodline, etc…). 
 
Contact Investigation 
1) Contacts are those with possible exposure to the source of infection.  
2) Examine all potential exposures based on possible sources and potential modes of 
transmission, investigating surrounding farms, fence-lines, co-mingling possibilities, 
veterinarian case histories  
 
Isolation, Work and Daycare Restrictions 
1) It does not infect humans, thus no restrictions 
2) Humans need to utilize appropriate biosecurity to prevent spread; appropriate cleaning 
protocols need to be utilized.  
 
Case Management  
 Report when negative test result is found. 
 
Contact Management 
14) Other at-risk animals should be quarantined, tested and if positive treated.  Once clinical 
signs have passed. 
15) Individuals should test all new animals entering the herd. 
16) Care should be taken to prevent iatrogenic transmission: disinfect or sterilize all 
equipment – including feeders, waterers, halters, lead ropes, etc…. 
 
Environmental Measures 
8) Maintaining good quality biosecurity standards when handling animals 
9) Utilize excellent insect control to help prevent spread of disease 
10) Avoid buying  and introducing untested animals, especially from endemic locations 
 
Education 
4) Educate veterinarians about disinfecting equipment to help prevent iatrogenic 
transmission.   
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MANAGING SPECIAL SITUATIONS 
 
A. Outbreak Investigation: 
VE is so rare in the United States that a single case needs to be treated as an outbreak. 
1) Notify KDA-DAH (785 296 2326) immediately. 
2) Active case finding will be an important part of any investigation. 
 
B. Intentional Contamination 
 
Safety Considerations: 
 
VE is not considered zoonotic and has not been shown to be a potential bioterrorism weapon. 
 
Post exposure prophylaxis (PEP): 
 
Post exposure prophylaxis is not utilized. 
 
Surveillance: 
 
Arrange for active surveillance for animals to maintain a VE free herd; to include any animal 
that presents with hypersalivation that is a new addition to the herd. Any animal that has oral 
lesions (vesicles) or has hoof or foot lesions needs to be tested for VE.  
 
C. Laboratory Exposure to Vesicular Stomatitis isolates: 
1) Laboratory exposure does not constitute harm at this time  
 
DATA MANAGEMENT AND REPORTING TO THE KDA-DAH  
 
A. Organize and collect data. 
 
B. Report data via the EpiTrax surveillance system. 
• All essential data that was collected during the investigation, especially data that helps 
to confirm or classify a case. 
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Vesicular Exanthema – Fact Sheet 
What is Vesicular Exanthema? 
Vesicular exanthema is a highly infectious viral disease of swine characterized by fevers and 
vesicles on the mouth, snout, coronary band and soles of the feet.   It affects mainly swine 
(rarely horses) and sea mammals; it has not shown to be infective to other species.  It also 
closely mimics three other vesicular diseases (foot-and-mouth disease, swine vesicular disease, 
vesicular stomatitis). The geographic distribution is variable depending on the outbreak, but 
vesicular exanthema was in the United States in the 1950’s but intense monitoring and 
surveillance has led to the disease being eradicated.  The United States is currently declared 
disease free.   
How is Vesicular Exanthema Transmitted? 
Transmission most likely occurs via one of three different ways; 1) feeding raw garbage to 
swine that contains infected pork scraps, 2) pig to pig, direct contact with infected swine, 3) 
swine that come into contact with infected fomites, including humans (on clothing or shoes), 
vehicles and equipment.  
What are the clinical signs of Vesicular Exanthema? 
The most common clinical signs will be vesicles and ulcers around the snout, nose, and mouth 
but may also be present around feet, coronary band, between claws or udder.  They start as 
vesicles and generally rupture to become erosions or ulcers.  Excessive salivation is often the 
only or first clinical sign noticed. Often a fever will be present along with going off-feed.  If it is 
noticed on the udder often mastitis will be seen.  Lameness or unwillingness to move is also a 
common clinical sign due to pain.  Weight loss can be severe due to the reluctance to eat.  
What is the incubation period for Vesicular Exanthema?  
The incubation period is most commonly 24-72 hours after exposure to the virus.  Swine will 
often have a fever and develop vesicles, which subsequently rupture 24-48 hours later; then 
the swine will have another fever episode anytime from 24-72 hours after the original vesicles 
rupture. Swine with active infections are more likely to spread disease, but recovered swine 
may also be undetected carriers of the virus.    
How is Vesicular Exanthema detected? 
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Presumptive diagnosis in swine is based on fever and the presence of vesicles, which break 
within 24–48 hours to form erosions. Diagnosis can be confirmed by ELISA, reverse 
transcriptase-PCR, complement-fixation tests, and electron microscopy on epithelial tissue, or 
after passage in swine tissue cultures.  All vesicular exanthema testing must be performed at an 
approved laboratory and positive results must be reported to state and federal animal health 
officials. 
Which animals have to be tested/screened? 
 Animals that are coming from areas where vesicular exanthema is currently endemic 
 Animals exhibiting clinical signs  
 Import/Export of animals- check with destination location for regulations 
What if my animal tests positive for Vesicular Exanthema? 
If there is a positive test, vesicular exanthema can be treated with supportive care; more 
importantly, steps need to be taken in order to prevent further spread.  Depending on the 
severity of the disease and if secondary bacterial infection is present, antibiotics may be utilized 
as well as medications to help deal with pain control and anti-inflammatories.  Quarantine of 
infected animals is crucial to limit spread and disinfectants need to be used on equipment and 
supplies. Most animals will clear the disease on their own after a period of time, but, a 
combination of antibiotics and disinfectants can be used.  An epidemiological investigation will 
need to be completed to determine cause and location of infection.  
What will happen to animals in close contact with the animal found to have Vesicular 
Exanthema? 
Animals will need to be quarantined, treated and re-tested.  Upon negative test result the 
animals are free to return to the herd.  The epidemiologic investigation will determine the 
infected animal’s movement history and identify other exposed animals. Management practices 
will be assessed to identify the potential of human spreading disease through use of 
contaminated equipment. Also, it is not recommended to feed raw garbage to swine.  
How can I protect my animals from Vesicular Exanthema? 
 Only purchase swine from geographic areas that are considered vesicular exanthema 
free. 
 Healthy animals are more disease resistant so provide good nutrition and regular 
veterinarian care. 
 Isolate new animals for at least 21 days before introducing them into the herd.  
Immediately isolate any ill animal.  
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 Implement an effective feed management- no raw garbage included in swine feed.  
 Use individual rather than communal feeders, clean and disinfect equipment and 
feeders regularly.  
 On farms where vesicular exanthema has been confirmed, handle healthy animals first, 
ill animals last.  
 Anyone handling infected animals should implement proper biosafety methods, 
including wearing latex gloves, appropriate protective clothing, shoe covers, etc….  
 Any swine that have a fever or vesicles or erosions should be isolated, tested and 
treated. 
 If you are sponsoring an event during an outbreak, require a current health certificate 
on every animal entering the venue.  
This fact sheet is for information only and is not intended for self-diagnosis or as a substitute 
for consultation. 
If you have any questions about the disease described above or think that your animal may 
have an infection, consult with your veterinarian. 
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Vesicular Exanthema Case Report Template 
Case Report Vesicular Exanthema 
Demographics 
Case # 
Investigator- 
 Name 
 Email 
 Phone # 
Veterinarian-  
 Name 
 Address 
 Cell # 
 Work # 
 Email 
 Clinic name 
Owner- 
 Date reported 
 Name 
 Address 
 County 
 DOB 
 Home # 
 Cell # 
 Work # 
 Email 
 
Any other humans in contact with suspect animal? 
 Name 
 Address 
 Phone 
 Date of contact with suspected animal 
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 Type of contact 
Animal Demographics 
Species 
Breed 
Gender 
State of Origin 
Age at disease onset 
Quarantined 
Deceased 
Was animal euthanized  
Were other animals exposed to the suspect animal? 
 If yes, are they sick or showing the same clinical signs  
 If no, were they isolated from the suspect animal? 
Exposure History 
How long has the animal been owned by the current owner? 
Was the owner in contact with the saliva or fluid from vesicles of the suspect animal? 
Was anyone else in contact with the saliva/fluid of the suspect animal? 
Where did owner get animal? 
What type of feed is the animal currently receiving? 
Where is the owner acquiring the feed? 
Other animals that are in contact with currently sick animal? Please describe 
 If yes, what species, how many, type of contact 
Has the animal traveled in the last 60 days? 
 If yes, please explain where, for what purpose and for how long 
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Has the animal been treated for the lesions? 
 If yes, with what (name, dose, concentration and duration) 
What date did the clinical signs resolve? 
Has this premise had animals with lesions similar to the current ones seen at any point prior to 
this occurrence? 
 
Laboratory information 
Name 
Number 
Specimen collection date 
Specimen collected 
Who collected specimen 
 Name, number  
 Was personal protection utilized to collect specimens? 
  If yes, please explain 
Name of test  
Result of test 
Symptomatic 
 Vesicles- located where?  
Mouth, muzzle, coronary band, feet, hooves, tongue, hard palate, udder 
 Hypersalivation 
 Fever 
 Anorexic- off feed or water 
 Weight loss 
 Mastitis 
 Lameness 
 Other, please explain 
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Vesicular Stomatitis 
Disease Management and Investigative Guideline 
CONTENT:          Version Date: 
Investigation Protocol: 
• Investigation Guideline        10/2013 
Supporting Materials (found in attachments): 
• Fact Sheet          10/2013 
• Case Report Form         10/2013 
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CASE DEFINITION  
Clinical Description for Public Health Surveillance: 
Vesicular stomatitis is a viral disease which can affect horses, cattle, swine, and occasionally 
sheep and goats. Additionally, numerous species of wild animals are susceptible including deer, 
bobcats and raccoons. The virus causing vesicular stomatitis can also infect humans, or anyone 
in contact with the infected animals. It most commonly occurs from late spring to late fall in the 
Southwest region of the United States and is often in proximity to rivers.  Blister-like lesions 
may form in the mouth and on the dental pad, tongue, lips, nostrils, hooves, and teats of 
infected animals. These vesicles swell and break, leaving very painful open sores.  These 
animals will often go off feed and water, suffer mild-to-severe weight loss, and may show signs 
of lameness.  Aside from the economic loss to livestock producers, vesicular stomatitis is 
significant because the outward signs are similar to those of foot-and-mouth disease. It is 
important to remember that horses do not get foot-and-mouth disease. The only method to 
differentiate between these diseases is through laboratory tests. 
Because of the similarity of vesicular stomatitis to foot-and-mouth disease, the potential 
negative impact on livestock production, and its public health implications, the U.S. Department 
of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS)works to keep this 
disease from becoming established in the United States. Vesicular stomatitis is recognized 
internationally as a reportable disease, and exports of livestock, horses, and animal products 
from the U.S. would be restricted if vesicular stomatitis were allowed to spread here.  
Case Classification:  
Confirmed:  A clinically compatible case that is laboratory confirmed.  
• A positive ELISA, complement fixation, virus neutralization or confirmed in culture by 
immunofluorescence test. 
Reverse Transcriptase Polymerase Chain Reaction RT-PCR can also be used.   
Suspected:  A clinically compatible illness that does not meet the confirmed case definition, but 
with one of the following:  
• Epidemiological link to a documented vesicular stomatitis exposure;  
• Evidence of having interaction with animal saliva or fluid from vesicles 
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LABORATORY ANALYSIS— 
1. Detection of the vesicular stomatitis virus (there are two distinct serotypes – Jersey 
and Indiana) in a clinical specimen (preferably the vesicular fluid,  epithelial tags from 
the lesions, or swabs from the lesions); there are three commonly used serologic tests 
1)ELISA, virus neutralization 2)complement fixation and 3) PCR test.  
2. Isolation (in cell culture or in a laboratory animal) 
A. Human Samples: 
• Contact KDHE to coordinate collection and submission of human samples. 
B. Animal Testing: 
• Please contact the laboratory prior to sending in samples.  It is important to handle 
samples carefully and accurately.  
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EPIDEMIOLOGY 
Vesicular Stomatitis is a viral disease characterized by vesicles and ulcers on the mouth, hooves 
and udder.  It can infect all different species of livestock but most commonly affects horses, 
cattle and swine. Humans are also susceptible. Currently there are numerous different 
serotypes that cause vesicular stomatitis, but two main serotypes are important in the United 
States (Jersey and Indiana); it also closely mimics three vesicular diseases not seen in the USA 
(foot-and-mouth disease, swine vesicular disease, vesicular exanthema of swine).   The 
geographic distribution is variable depending on the strain.  There have been outbreaks in 
North, Central and South America.   
DISEASE OVERVIEW 
A. Agent: 
 The viruses are members of the family Rhabdoviridae and genus Vesiculovirus. They are bullet 
shaped and composed of a single strand of negative sense RNA.   
B. Clinical Description: 
Generally there will be a mild fever, but often this isn’t seen by the time the animal is observed 
and examined by a veterinarian.  Hypersalivation is often the first sign of disease.  Vesicles in 
the oral cavity are rarely observed due to rupture soon after formation; therefore, ulcers are 
the most common lesion observed during primary examination. Ulcers and erosions of the oral 
mucosa, sloughing of the epithelium of the tongue, and lesions at the mucocutaneous junctions 
of the lips and nostrils are commonly seen in both cattle and horses. Ulcers and erosions on the 
teats are not uncommon in cattle and may result in secondary cases of mastitis in dairy cows. 
Erosions at the coronary band are observed in some cattle, horses, and pigs, with subsequent 
development of lameness. Crusting lesions of the muzzle, ventral abdomen, sheath, and udder 
of horses have been seen in the outbreaks in the western USA.  Anorexia is often seen due to 
the oral lesions and lameness is often seen due to the hoof or foot lesions; both of these are 
generally short in duration as the disease is self-limiting with resolution usually happening 
within 2 weeks.  Neutralizing antibodies persist, up to or greater than 5 years, but re-infection 
can occur.  
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C. Reservoirs:  
The main reservoir is the sand fly, although rodents and non-human primates may also harbor 
the virus.  Grasshoppers have also been implicated as a potential reservoir for the vesicular 
stomatitis virus in cattle.   
D. Mode(s) of Transmission:  
Vesicular stomatitis spread is not well understood, however, there are believed to be three 
main modes of transmission.  Insect vectors, mechanical transmission and animal movement or 
transport are all believed to play a role in the transmission.  One type of vesicular stomatitis is 
known to be spread by sandflies. Once introduced onto a property, the disease apparently 
moves from animal to animal by contact or exposure to saliva or fluid from ruptured vesicles.  
Humans can contract vesicular stomatitis by not following proper biosafety practices when 
handling affected animals. Prevalence of this disease in humans may be under-reported 
because it is self-limiting and often goes undetected or is misdiagnosed. 
E. Incubation Period:  
In general, the incubation period is generally 2 to 8 days.   
F. Period of Communicability:  
Animals have been shown to shed the virus in their saliva and from the fluid in the vesicles as 
they rupture; once these vesicles are healed they generally are not infective.  Humans need to 
utilize proper biosecurity and quarantine when handling infected animals for 30 days after the 
last clinical sign is seen 
G. Susceptibility and Resistance:  
All mammals are susceptible to vesicular stomatitis; generally pigs have a higher mortality rate 
as compared to other animals. Generally morbidity is very high and mortality is low.  
H. Treatment:  
Treatment consists of supportive care, usually antibiotics are prescribed with secondary 
infections.  The lesions are extremely painful and thus pain control medications are often 
added.  In addition, some animals will need to be given soft or wet food to aid in ease of 
mastication.  Some animals, that will tolerate it, will benefit from mild antiseptic  
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mouth rinses.  Good insect control is also beneficial in preventing the spread of vesicular 
stomatitis.  Antiseptic cleaning of the open wounds can also promote healing. 
I. Vaccine:  
There is no vaccine available in the United States.  
 
NOTIFICATION TO PUBLIC HEALTH AUTHORITIES 
Vesicular Stomatitis infections shall be designated as infectious or contagious in their nature, 
and cases or suspect cases shall be reported within 24 hours: 
 
1. Veterinarians and producers: report to KDA-DAH (see below) 
2. Laboratories: report to KDA-DAH (see below) 
 
Kansas Department of Agriculture – Division of Animal Health (KDA-DAH) 
Phone: 1-785-296-2326 
Fax: 1-785-296-1765 
Outbreaks, unusual occurrences of VS, should be reported WITHIN 7 days by telephone to 1-
785-296-2326.  
 
INVESTIGATOR RESPONSIBILITIES 
1) Use current case definition, to confirm diagnosis. 
2) Conduct a case investigation to identify potential source of infection. 
3) Conduct contact investigation to identify additional cases. 
4) Initiate control and prevention measures to prevent spread of disease. 
5) Complete and report all information requested via the state electronic surveillance system. 
6) As appropriate, use the disease fact sheet to educate individuals or groups. 
STANDARD CASE INVESTIGATION AND CONTROL METHODS 
Case Investigation 
1) Contact the veterinarian who ordered testing of the case and obtain the following 
information.  
 Using the case report form, identify any symptoms of VS: 
− Record onset date  
− Determine if the onset was acute or insidious 
 Examine the laboratory testing that was done to ensure all testing that could 
confirm the case has been reported in Epi-Trax. 
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 Examine and record the therapy that the case received. 
 Collect case demographic data and contact information (birth date, county, 
sex, addresses for previous year) 
 Record outcomes 
 Collect mingling history from previous year and note any previous contact with positive 
VS animals or premises previous documented positive 
2) Investigate epi-links among cases (clusters from same facility, county, herd, farm or 
bloodline, etc…). 
 
Contact Investigation 
1) Contacts are those with possible exposure to the source of infection.  
2) Examine all potential exposures based on possible sources and potential modes of 
transmission, investigating surrounding farms, fence-lines, co-mingling possibilities, 
veterinarian case histories  
 
Isolation, Work and Daycare Restrictions 
1) Monitor for any general flu-like symptoms or illness, as well as, if any lesions occur in 
humans after handling infected animals 
2) Humans need to utilize appropriate biosecurity to prevent spread  
 
Case Management  
 Report when negative test result is found. 
 
Contact Management 
1) Other at-risk animals should be quarantined, tested and, if positive, treated.  Once 
clinical signs have passed, animals need to be quarantined for an additional 30 days 
before allowing them to rejoin the herd.    
2) Individuals should test all new animals entering the herd. 
3) Care should be taken to prevent iatrogenic transmission: disinfect or sterilize all 
equipment – including feeders, waterers, halters, lead ropes, etc…. 
 
Environmental Measures 
1) Maintaining good quality biosecurity standards when handling animals 
2) Utilize excellent insect control to help prevent spread of disease 
3) Avoid buying  and introducing untested animals, especially from endemic locations 
 
Education 
1) Educate veterinarians about disinfecting equipment to help prevent iatrogenic 
transmission.   
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MANAGING SPECIAL SITUATIONS 
 
A. Outbreak Investigation: 
VS is so rare in the United States that a single case needs to be treated as an outbreak. 
1) Notify KDA-DAH (785 296 2326) immediately. 
2) Active case finding will be an important part of any investigation. 
 
B. Intentional Contamination 
 
Safety Considerations: 
 
Risks to public health, health care and emergency response personnel are individually 
significant for disease or illness. VS has not been shown to be a potential bioterrorism weapon. 
 
Post exposure prophylaxis (PEP): 
 
Post exposure prophylaxis is utilized; humans need to contact their physician to determine 
course of treatment 
 
Surveillance: 
 
Arrange for active surveillance for animals to maintain a VS free herd; to include any animal 
that presents with hypersalivation that is a new addition to the herd. Any animal that has oral 
lesions (vesicles) or has hoof or foot lesions needs to be tested for VS especially if located in the 
Western states (mainly New Mexico).  
 
C. Laboratory Exposure to Vesicular Stomatitis isolates: 
1) Laboratory exposure does not constitute harm at this time  
 
DATA MANAGEMENT AND REPORTING TO THE KDA-DAH  
 
A. Organize and collect data. 
 
B. Report data via the EpiTrax surveillance system. 
• All essential data that was collected during the investigation, especially data that helps 
to confirm or classify a case. 
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Vesicular Stomatitis – Fact Sheet 
What is Vesicular Stomatitis? 
Vesicular Stomatitis is a viral disease characterized by vesicles and ulcers on the mouth, hooves 
and udder.  It can infect all different species of livestock but most commonly affects horses, 
cattle and swine. Humans are also susceptible. Currently there are numerous different 
serotypes that cause vesicular stomatitis, but two main types are important in the Western 
hemisphere; it also closely mimics three vesicular diseases not seen in the USA (foot-and-mouth 
disease, swine vesicular disease, vesicular exanthema of swine).   The geographic distribution is 
variable depending on the strain.  There have been outbreaks in North, Central and South 
America.   
How is Vesicular Stomatitis Transmitted? 
Transmission is not well understood.  Most likely it is transmitted via insect vectors (sand flies, 
blackflies, culicoides midges, mosquitos).  Grasshoppers have also been implicated in cattle 
when ingested.   Once it is in a herd, it can be transmitted from animal-to-animal by direct 
contact; this includes on fomites including milking machines and equipment.  Humans most 
commonly are infected by contact with lesions or secretions from infected animals. They can 
also get vesicular stomatitis via insect bites and aerosol infection has happened in laboratory 
settings  
What are the clinical signs of Vesicular Stomatitis? 
The most common clinical signs will be vesicles, papules, erosion and ulcers usually around the 
mouth but may also be present around feet, prepuce or udder.  They start as vesicles and 
generally rupture to become erosions or ulcers.  Excessive salivation is often the only or first 
clinical sign noticed. Often a fever will be present along with anorexia.  If it is noticed on the 
udder often mastitis will be seen.  In pigs, often times the vesicles start on the feet and the first 
clinical sign noted will be lameness.  These lesions are varied based on the species, but the 
lesions are painful and will cause animals to go off-feed and not want to drink.  Weight loss may 
be severe and milk production can suddenly drop. Some animals will slough skin around muzzle, 
mouth or nostrils and there may be extreme bad breath or bleeding from the mouth.   Usually 
vesicular stomatitis will run its course in 2-3 weeks and the animals will recover.  There is 
evidence that pigs are more likely to die with vesicular stomatitis.   
What is the incubation period for Vesicular Stomatitis?  
The incubation period is most commonly 2-8 days; the virus is easily killed with sunlight, heat 
and disinfectants, but can live 3-4 days on fomites that have not been properly cleaned.  
How is Vesicular Stomatitis detected? 
The preferred way to diagnose vesicular stomatitis is to detect the viral antigens.  It can be 
isolated in culture via immunofluorescence, complement fixation or ELISAs as well as electron 
microscopy can be used.  Reverse-transcriptase- polymerase chain reaction (RT-PCR) can also 
be used; animals will general develop antibodies within 5-8 days post infection. All vesicular 
stomatitis testing must be performed at an approved laboratory and positive results must be 
reported to state and federal animal health officials. 
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Which animals have to be tested/screened? 
 Animals that are coming from areas where vesicular stomatitis is currently 
endemic 
 Animals exhibiting clinical signs  
 Import/Export of animals- check with destination location for regulations 
What if my animal tests positive for Vesicular Stomatitis? 
If there is a positive test, vesicular stomatitis can be treated. Depending on the severity of the 
disease and if infection is present, antibiotics may be utilized as well as medications to help deal 
with pain control and anti-inflammatories.  Quarantine of infected animals is crucial to limit 
spread and disinfectants need to be used on equipment and supplies. Most animals will clear 
the disease on their own after a period of time, but usually, a combination of antibiotics and 
disinfectants is usually used.  An epidemiological investigation will need to be completed to 
determine cause and location of infection.  
What will happen to animals in close contact with the animal found to have Vesicular 
Stomatitis? 
Animals will need to be quarantined, treated and re-tested.  Upon negative test result the 
animals will need to be isolated for an additional 30 days to prevent spread.  The epidemiologic 
investigation will determine the infected animal’s movement history and identify other exposed 
animals. Management practices will be assessed to identify the potential of iatrogenic spread of 
disease through use of contaminated equipment.  
How can I protect my animals from Vesicular Stomatitis? 
 Only purchase animals from geographic areas that are considered vesicular stomatitis 
free. 
 Healthy animals are more disease resistant so provide good nutrition, regular exercise, 
deworming and routine vaccinations. 
 Isolate new animals for at least 21 days before introducing them into the herd.  
Immediately isolate any ill animal.  
 Implement an effective insect control program; keep stables, barns, and pens clean and 
dry.  
 Use individual rather than communal feeders; clean and disinfect equipment and 
feeders regularly.  
 On farms where VS has been confirmed, handle healthy animals first, ill animals last.  
 Anyone handling infected animals should implement proper biosafety methods, 
including wearing latex gloves.  
 If you are sponsoring an event during an outbreak, require a current health certificate 
on every animal entering the venue.  
This fact sheet is for information only and is not intended for self-diagnosis or as a substitute 
for consultation. 
If you have any questions about the disease described above or think that your animal may 
have an infection, consult with your veterinarian. 
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Appendix G-3 
Vesicular Stomatitis Case Report Template 
Case Report Vesicular Stomatitis 
Demographics 
Case # 
Investigator- 
 Name 
 Email 
 Phone # 
Veterinarian-  
 Name 
 Address 
 Cell # 
 Work # 
 Email 
 Clinic name 
Owner- 
 Date reported 
 Name 
 Address 
 County 
 DOB 
 Home # 
 Cell # 
 Work # 
 Email 
 
Any other humans in contact with suspect animal? 
 Name 
 Address 
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 Phone 
 Date of contact with suspected animal 
 Type of contact 
 
 
Animal Demographics 
Species 
Breed 
Gender 
State of Origin 
Age at disease onset 
Quarantined 
Deceased 
Was animal euthanized  
Were other animals exposed to the suspect animal 
 If yes, are they sick or showing the same clinical signs  
 If no, were they isolated from the suspect animal 
Exposure History 
How long has the animal been owned by the current owner? 
Was the owner in contact with the saliva or fluid from vesicles of the suspect animal? 
Was anyone else been in contact with the saliva/fluid of the suspect animal? 
Where did owner get animal? 
Other animals that are in contact with currently sick animal? Please describe 
 If yes, what species, how many, type of contact 
Has the animal traveled in the last 60 days 
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 If yes, please explain where, for what purpose and for how long 
Has the animal been treated for the lesions? 
 If yes, with what (name, dose, concentration and duration) 
What date did the clinical signs resolve? 
Was the animal quarantined for an additional 30 days after last seen clinical sign? 
 
Laboratory information 
Name 
Number 
Specimen collection date 
Specimen collected 
Who collected specimen 
 Name, number  
 Was personal protection utilized to collect specimens? 
  If yes, please explain 
Name of test  
Result of test 
Symptomatic 
 Vesicles- located where?  
Mouth, muzzle, coronary band, feet, hooves, tongue, hard palate 
 Hypersalivation 
 Fever 
 Anorexic- off feed or water 
 Lameness 
 Other, please explain 
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 Case Report Form       10/2013 
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CASE DEFINITION  
Clinical Descriptions for Public Health Surveillance: 
 An illness characterized by infertility or sudden abortion. Other symptoms include one 
or more of the following: prolonged mucopurulent vaginal discharge, still births, 
epididymitis, unwillingness to mate, decreased ejaculate, and recurrent uveitis.  
Laboratory Criteria for Case Classification: 
 Definitive:            
o Culture and identification of Brucella from clinical specimens 
o Evidence of fourfold or greater rise in Brucella antibody titer between acute- and 
convalescent-phase serum specimens obtained greater than or equal to 2 week 
apart 
 Presumptive: 
o Positive reading using 2-mercaptoethanol Rapid Slide Agglutination Test (ME-
RSAT); or the Tube Agglutination Test (TAT) with a 1:200 titer reading gives 
evidence of an acute reading. 
o Detection of Brucella DNA in a clinical specimen by polymerase chain reaction 
(PCR) assay 
Case Classification: 
 Confirmed: A clinically compatible illness with definitive laboratory evidence of Brucella 
Infection/ isolation of Brucellae from a clinical specimen by culture 
 Probable: A clinically compatible case and elevated antibody serology; or detection of 
Brucella  nucleic acids in a clinical specimen by amplification of a specific target by 
polymerase chain reaction assay 
 Suspect: A clinically compatible case that is epidemiologically linked to a confirmed 
case. 
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EPIDEMIOLOGY 
Brucellosis is a zoonotic disease; humans are accidental hosts. There are different species of 
zoonotic Brucella, including B. melitensis, B. suis, B. abortus and B. canis. There are also two 
species that are not considered zoonotic (B. ovis and B. neotomae).  It is most often seen in 
breeders, veterinarians, laboratory workers, and other people that directly work with 
susceptible animals. B. melitensis primary hosts are sheep and goats and has been considered 
eradicated from the USA since the early 1970s.  Cases will still arise sporadically with humans 
who have traveled to areas where the disease is present and have consumed unpasteurized 
dairy products.  B. suis primary hosts are swine and most commonly will cause a problem if 
hunters field dress whild hogs.  B. abortus primary host is cattle and is considered eradicated 
from the USA except for wild bison/elk located in Yellowstone National Park.  B. canis primary 
hosts are canine and is thought to be present in the USA but regularly testing is not commonly 
completed in the USA.  Some beliefs for the low prevalence of canine brucellosis in the United 
States can be attributed to underreporting. For the canine brucellosis status of other states, 
refer to the USDA-APHIS monthly reports at 
http://www.aphis.usda.gov/animal_health/animal_diseases/brucellosis/. 
DISEASE OVERVIEW 
A. Agent: 
Brucella is caused by gram negative non-motile aerobic intracellular coccobacillus. Once 
in the environment it is susceptible to common household cleaning supplies and direct 
sunlight. 
 
B. Clinical Description: 
Signs include but are not limited to: epididymitis, testicular atrophy, orchitis, scrotal 
dermatitis, prostatitis, infertility, loss of libido, diskospondylitis, mucosal vaginal 
secretions, and sudden abortion or reabsorption. 
 
C. Reservoirs: 
B. Melitensis hosts are sheep and goats. 
B. suis hosts are swine. 
B. abortus hosts are cattle.  
B. canis has only been known to be acquired from canines. 
 
D. Mode of Transmission: 
Transmission occurs through direct contact with infected animals’ fluids and/or tissues 
including: urine, vaginal discharges, aborted fetuses, placentas, milk and ocular fluids. 
Airborne transmission may occur through inhalation of aerosols in lab settings. Human-
to-human transmission has not been known to occur. 
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E. Incubation Period: 
Variable incubation period, ranging from 5-60 days but may be several months; illness 
most commonly occurs about 1 month after exposure. 
 
F. Period of Communicability: 
Animals may be infectious for years. 
 
G. Susceptibility and Resistance: 
Susceptibility is determined by occupation; there is no documented case of being 
resistant. 
 
H. Treatment: 
Administer a combination of rifampin or streptomycin and doxycycline for at least 6 
weeks in humans. In animals euthanasia is suggested since it has been known for 
animals to relapse after being treated. Treatment is only permitted in canines and 
humans.  
 
I. Vaccine: 
There is a vaccine available for cattle (OCV) that must be administered by a licensed 
veterinarian.  Each calf must be identified as receiving the vaccination in compliance 
with state and federal regulations.  
There is no vaccine currently available for humans or canines.  
NOTIFICATION TO PUBLIC HEALTH AUTHORITIES 
Brucellosis infections shall be designated as infectious or contagious in their 
nature, and cases or suspect cases shall be reported within seven days: 
 
1. Health care providers and hospitals: report to the local public health 
Jurisdiction, KDA-DAH, or KDHE-BEPHI (see below) 
2. Local public health jurisdiction: report to KDA-DAH or KDHE-BEPHI (see below) 
3. Laboratories: report to KDA-DAH or KDHE-BEPHI (see below) 
4. KDA-DAH or KDHE-BEPHI will contact the local public health jurisdiction by phone 
within one hour of receiving any suspected brucellosis report. 
 
Kansas Department of Agriculture – Division of Animal Health (KDA-DAH) 
Phone: 1-785-296-2326 
Fax: 1-785-296-1765 
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Kansas Department of Health and Environment (KDHE) 
Bureau of Epidemiology and Public Health Informatics (BEPHI) 
Phone: 1-877-427-7317 
Fax: 1-877-427-7318 
 
Outbreaks, unusual occurrences of brucellosis, and suspect acts of terrorism 
should be reported WITHIN 4 HOURS by telephone to 1-877-427-7317. 
 
Further responsibilities of state and local health departments to the CDC: 
 
As a nationally notifiable condition, multiple brucellosis cases that are 
temporally/spatially clustered require an IMMEDIATE, URGENT report to the 
Center of Disease Control and Prevention (CDC). 
 
INVESTIGATOR RESPONSIBILITIES 
1) Use current case definition, to confirm diagnosis with the medical provider. 
2) Conduct a case investigation to identify potential source of infection. 
3) Conduct contact investigation to identify additional cases. 
4) Identify whether the source of infection is major public health concern. 
5) Initiate control and prevention measures to prevent spread of disease. 
6) Complete and report all information requested via the state electronic 
surveillance system. 
7) As appropriate, use the disease fact sheet to educate individuals or groups. 
STANDARD CASE INVESTIGATION AND CONTROL METHODS 
Case Investigation 
1) Contact the veterinarian who ordered testing of the case and obtain the 
following information. (This includes medical records for hospitalized patients.) 
 Using the case report form, identify any symptoms of brucellosis: 
− Record onset date (if a reoccurrence – record the earliest onset date) 
− Record the duration of the current illness in weeks 
− Determine if the onset was acute or insidious, recording symptoms 
 Examine the laboratory testing that was done to ensure all testing that could 
confirm the case has been reported in Epi-Trax. 
 Examine and record the therapy that the case received, if any. 
 Collect owner’s demographic data and contact information (birth date, county, 
sex, occupation, address, phone number(s)) 
 Record outcomes: recovered or date of death 
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2)  Interview the owner to determine source and risk factors; focus on a 6 
month incubation period prior to illness onset. 
 Occupation: Laboratory worker, veterinarian, or persons handling animals and animal 
by-products 
 Travel to Brucella endemic areas (i.e., the Mediterranean Basin, South and 
Central America, Eastern Europe, Asia, Africa, Caribbean and Middle East) 
 Contact with potentially infected animals or their tissues, particularly 
postpartum fluid or tissues; 
− Potential contact with cattle, swine, goats, sheep, horses, and dogs 
3) Investigate epi-links among cases (clusters, household, co-workers, etc). 
 For suspected outbreaks refer to Managing Special Situations section. 
 
 
Contact Management- in humans 
1) Symptomatic acquaintances, household members, associates, or co-workers     should be 
strongly urged to contact their physician for a medical evaluation. 
2) Broader symptoms of brucellosis should be passively monitored for six months 
     from the last exposure. Broader symptoms include: 
 Acute: fever, chills, headache, low back pain, joint pain, malaise, diarrhea 
 Sub-Acute: malaise, muscle pain, headache, neck pain, fever, sweats 
 Chronic: anorexia, weight loss, abdominal pain, joint pain, depression,  
constipation 
3) Recommend PEP to those contacts with high-risk exposures to Brucella: 
4) For laboratory personnel refer to managing special situations. 
 
Environmental Measures 
1) Exercise care when handling placenta and fetus from aborted animals. 
2) Disinfect contaminated areas with a bleach solution or other commercial disinfectant. 
 
Education 
1) Educate high-risk workers (i.e., veterinarians, kennel breeder etc.) about the risk of 
brucellosis and stress methods to reduce occupational exposure such as proper ventilation, 
appropriate carcass disposal and barrier precautions. 
 
MANAGING SPECIAL SITUATIONS 
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A. Outbreak Investigation: 
There are no formal outbreak definitions; however, the investigator may consider the 
possibility of an outbreak when there is an unusual clustering of cases in time and/or space. 
1) Notify KDA-DAH (785 296 2326) or KDHE (1-877-427-7317) immediately. 
2) Active case finding will be an important part of any investigation. 
 
B. Intentional Contamination 
Brucella is a potential bioterrorism weapon. If the case has no known exposures or is not 
employed in an occupation that is prone to exposure, then consider a bioterrorist event. An 
attack may take the form of dissemination of an aerosol among a large gathering of people or 
by the contamination of food or water. Because the laboratory confirmation could be delayed, 
specific epidemiological, clinical, and microbiological findings that suggest an intentional 
release of brucella should result in the issue of a health alert. 
If suspected: 
1) Notify local law enforcement, the local Health Officer, the on-call epidemiologist (local) and 
KDHE (1-877-427-7317) immediately. 
2) Implement “Chain of Custody” procedures for all samples collected, as they will be 
considered evidence in a criminal investigation. 
3) Work to define population at risk which is essential to guide response activities. Public health 
authorities will play the lead role in this effort, but must consult with law enforcement, 
emergency response and other professionals in the process. The definition may have to be re-
evaluated and redefined at various steps in the investigation and response. 
4) Once the mechanism and scope of delivery has been defined, identify symptomatic and 
asymptomatic individuals among the exposed and recommend treatment and/or 
chemoprophylaxis. 
5) Establish and maintain a detailed line listing of all cases and contacts with accurate 
identifying and locating information. 
 
 
Diagnosis: 
 Veterinarians who suspect brucellosis should promptly collect blood or bone 
marrow for culture. Liver, spleen, joint fluid and abscesses can also be cultured. 
Serum collected for serologic diagnosis, requires an acute specimen collected as 
soon as possible after onset and a convalescent phase specimen should be 
collected > 14 days after the acute specimen. 
 Alert the laboratory to the possibility of Brucella and need for special safety 
procedures. 
 Serology and Rapid Testing: The standard laboratory test for Brucella antibody is  
the tube agglutination test, but the more rapid simple slide agglutination test is  
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commonly used in commercial and hospital laboratories. The slide agglutination 
test is 97%--100% sensitive and may be as low as 88% specific. If used in a 
population with a low prevalence of disease, the risk for a false-positive result is 
high. Therefore, diagnostic laboratory testing should be integrated with 
epidemiologic investigation when assessing potential covert biological terrorism 
events to rule out false positive laboratory findings. PCR and ELISA testing may 
also be available. 
 Biopsy specimens: Brucella spp. can be identified through direct examination of 
biopsy specimens using direct fluorescent antibody stains. 
 Cultures: Brucella spp. will grow only in aerobic blood culture bottles after 2-4 
days; followed by isolation as typical colonies on BAP and CHOC within 48 hours. 
Presumptively identified as a small, gram-negative coccobacilli that is oxidase, 
catalase and urea positive. Confirmatory identification is made by agglutination 
with specific antiserum in a reference laboratory. 
 
Treatment: 
 Drug-resistant organisms might be used as a weapon-, conduct antimicrobial 
susceptibility testing quickly and alter treatments as needed. 
 
Post exposure prophylaxis (PEP): 
 In most brucellosis threat situations post exposure prophylaxis is not 
recommended. However, if the level of suspicion is high, exposed individuals 
may begin antimicrobial therapy if a definitive determination cannot be made 
within 5 days. 
Surveillance: 
 Arrange for active surveillance for 4 weeks for the development of febrile illness 
and 6 months of passive monitoring for other signs and symptoms of brucellosis 
among all animals exposed. 
 
 
C. Laboratory Exposure to Brucella isolates: 
1) Determine number of workers exposed to Brucella isolates and classify exposures into 
high- and low-risk. 
2) Recommend PEP for workers with high-risk exposures to Brucella. 
3) Discuss PEP with workers with only low-risk exposures. 
4) Obtain baseline serum samples from all workers as soon as possible after potential 
Brucella exposure is recognized.  
5) Arrange for serologic testing on all workers exposed at 2, 4, 6, and 24 weeks post 
exposure using agglutination test. 
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6) Arrange for regular active surveillance for the development of febrile illness (for 4 
weeks) or other signs and symptoms of brucellosis (for 6 months). 
 
DATA MANAGEMENT AND REPORTING TO THE KDA-DAH & KDHE 
 
A. Organize and collect data. 
 
B. Report data via the Kansas electronic surveillance system. 
• All essential data that was collected during the investigation, especially data 
that helps to confirm or classify a case. 
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What is Brucellosis? 
Brucellosis is the diseased caused by the Brucella bacteria.  It is mainly a disease of animals but 
can be transmitted to humans.  The most common animals to be infected with Brucella are 
cattle, swine and bison. It is endemic in some countries; it can be spread by drinking raw milk or 
eating unpasteurized cheeses.  It is not common in the USA, but a small reservoir is seen in the 
herd of wild bison/elk in Yellowstone 
How is Brucella Transmitted? 
Most animals get Brucella by artificial insemination or natural breeding with an infected animal. 
They also get it through direct contact with a contaminated environment or from eating 
contaminated feed.  Cows will often lick the placenta and aborted fetuses and spread Brucella.  
It can also be transmitted to calves through infected milk.  The spread from one premise to 
another premise often occurs by bringing on new animals that were previously infected with 
Brucella.  Dogs can also get Brucella from inhaling or licking infected fetal membranes or urine.  
People can be exposed by eating contaminated food, by inhalation or getting the bacteria into a 
wound.  Most commonly people will be exposed by eating unpasteurized cheese or drinking 
raw milk.  Inhalation can be an issue for high risk occupations such as veterinarians, 
slaughterhouse or laboratory workers.   
What are the clinical signs of Brucellosis? 
The bacteria thrives in the reproductive tract.  Brucella will primarily cause infertility, weak born 
animals, retained placentas and abortions. In cattle, most commonly abortion will happen with 
heifers and usually between 5-7 months of gestation; these cows will typically carry future 
pregnancies full term.  Males may develop scrotal inflammation, go off feed, have a fever and 
act lethargic.  Sometimes horses will develop and open sore in the withers region.  In dogs, 
brucellosis can cause abortion, enlarged spleen and lymph nodes, eye, kidney and spinal disc 
inflammation and multiple-joint arthritis. Many animals may not show clinical signs.  In humans, 
clinical signs are often flu-like with long-term recurrent fevers, joint pain and fatigue.   
What is the incubation period for Brucellosis? 
The incubation period is variable and can ranges from 2 weeks to over a year.  Most commonly 
there will be a positive reaction to the test within 30-60 days after infection.  
How is Brucella detected? 
The most commonly used tests for Brucella are the blood agglutination test and the card test.  
These can be done in the field and are utilizing antigen containing dead Brucella organisms; 
these tests are reliable, quick and easy to use.  There are other testing options available and 
involve culturing Brucella organisms from infected tissues, milks or aborted calves.  Direct 
culture of the organism from a dead puppy or blood can be used in dogs, but is sometimes 
difficult. All Brucella testing must be performed by a licensed veterinarian utilizing an approved 
laboratory (if culturing) and positive results must be reported to state and federal animal health 
officials. 
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Which animals have to be tested/screened? 
 All cattle/bison over the age of 6 months except steers and any spayed females.  
 Any dogs that abort late in gestation (usually 45-60 days) 
 Active stud dogs especially if part of a large kennel 
 Any animal exhibiting clinical signs 
 Any animals coming from an endemic area 
What if my animal tests positive for Brucella? 
If there is a positive test, Brucella cannot be treated in livestock. Some animals will recover 
after a period of time, but most commonly the clinical signs disappear but animals remain 
infected.  These animals are dangerous sources of infection for animals they may mingle or 
mate with.  For cattle, there is a vaccine that can be given.  There was a vaccine in cattle called 
strain 19 that was utilized for many years, but a newer vaccine has been approved called RB51.  
It has less adverse side effects than strain 19 and doesn’t interfere with antibodies produced on 
the testing used.  This vaccine is most commonly given between 4-6 months of age and the 
animal is tattoed/ear tagged..  It also has to be administered by a licensed veterinarian.  RB51 is 
currently approved for cattle only.  In dogs, there is no effective treatment or vaccine.  One way 
to help prevent sexual transmission of the disease is to have your pet spayed or neutered.  For 
all animals, the only permanent way to stop the disease from spreading is euthanasia.  
How can I protect my animals from Brucella? 
 Obtain a negative Brucella test before purchasing a new animal to confirm a negative 
disease status and to reduce the risk of disease entry onto the premises  
 Only purchase animals from geographic areas that are considered Brucella free, 
quarantine and re-test animals once on your premise 
 Disinfect or sterilize all equipment, instruments and premises 
 Utilize appropriate sanitation procedures and pasteurization of milk 
 Vaccination 
This fact sheet is for information only and is not intended for self-diagnosis or as a substitute 
for consultation. 
If you have any questions about the disease described above or think that your animal may 
have an infection, consult with your veterinarian. 
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Case Report : Brucella 
Demographics 
Case # 
Investigator- 
 Name 
 Email 
 Phone # 
Veterinarian-  
  Name 
 Address 
 Cell # 
 Work # 
 Email 
 Clinic name 
Owner- 
 Date reported 
 Name 
 Address 
 County 
 Home # 
 Cell # 
 Work # 
 Email 
Animal Demographics 
Species 
Breed 
Gender 
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Age at diagnosis 
State of Origin 
County of Origin 
 
Quarantined 
 If yes, how long? start date of quarantine? 
Is this the first time Brucella has been diagnosed on this premises  
Were other animals exposed to the suspect animal 
 If yes, have they been tested for Brucella 
  Results and testing protocols utilized 
 If no, were all other animals isolated from the suspect animal 
Exposure History 
How long has the animal been owned by the current owner? 
Where did owner get animal? 
 If previously owned – please provide history of name, address and phone of previous 
owner(s) 
Has the suspect animal been in contact with any other species of animals? 
Has the animal mated with another animal?  
 -If yes, when and what other animal? 
 - Are those animals ill? 
Who has handled the suspect animal? 
 -Name, contact information 
Was the animal on any medications at the time of testing 
 If yes, name, dose, concentration, duration 
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At a positive diagnosis, was the animal treated 
 If yes, treatment type, dose, concentration and duration 
 Currently being treated 
 Has the animal been vaccinated for Brucella 
 Has the animal been sent to slaughter or euthanized 
   
Is the animal symptomatic 
• Abortion 
• Vaginal discharge 
•  Weak born animals 
• Still birth 
• Pyometra 
•            Infertility 
• Epididymitis 
• UTI 
• Fever 
• Lethargy 
• Diskospondylitis 
• Ocular lesions 
•            Enlarged lymph nodes 
• Other, please explain 
 
Laboratory information 
Name 
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Number 
Specimen collection date 
Specimen collected 
Who collected specimen 
 Name, number  
How was specimen collected- please be very specific  
 Was specimen kept in an incubator or warmed 
 How long between sample collect and submission 
Name of test  
Result of test 
 Organism name 
 Organism species 
 Organism serotype or serogroup (if known) 
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Tuberculosis  
Investigation Guideline 
 
Content:         Version Date: 
Investigation Protocol: 
 Investigation Guideline      10/2013   
Supporting Materials found in attachments: 
 Fact Sheet        10/2013 
 Case Report Form       10/2013 
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CASE DEFINITION  
Clinical Descriptions for Public Health Surveillance: 
 Tuberculosis is a contagious disease caused by an infection in the lymph nodes which is 
then spread to other organs like the lungs. This disease can infect all mammals, and 
before control measures were adopted, was one of the major diseases of domestic 
animals and humans.  Bovine tuberculosis is a disease caused by the bacterium 
Mycobacterium bovis. It can infect many species of animals; cattle and bison most 
commonly. Bovine tuberculosis can spread to humans even though human cases are 
most commonly caused by Mycobacterium tuberculosis. Tuberculosis is common in 
developing countries, a source of economic loss, and a serious health threat to humans.  
Laboratory Criteria for Case Classification: 
 Definitive:            
o Culture and identification of M. bovis from clinical specimens 
o Detection of M. bovis DNA in a clinical specimen by polymerase chain reaction 
(PCR) assay 
 
 Presumptive: 
o Positive tuberculin skin fold test 
o Gamma interferon test 
Case Classification: 
 Confirmed: A clinically compatible illness with definitive laboratory evidence of 
Tuberculosis Infection/ isolation of M. bovis from a clinical specimen by culture 
 Probable: A clinically compatible case and elevated antibody serology; or detection of 
M. bovis  nucleic acids in a clinical specimen by amplification of a specific target by 
polymerase chain reaction assay 
 Suspect: A clinically compatible case that is epidemiologically linked to a confirmed 
case. 
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EPIDEMIOLOGY 
Tuberculosis is an infectious, granulomatous disease and is considered one of the oldest 
recognized diseases in the world.  About 1/3 of the human population are infected with 
tuberculosis (TB).  Tuberculosis in animals is a worldwide problem; in the USA there has been a 
subtle resurgence of the TB in a few species of wild animals (white tail deer, foxes, coyotes, 
bobcats and opossums).  Tuberculosis is a zoonotic disease; humans are accidental hosts of the 
cattle M. bovis species. There are different species of zoonotic Tuberculosis, including M.bovis, 
M. tuberculosis and M. avium-intracellulare. Tuberculosis can be either chronic or rapidly 
progressive, with a wide variety of clinical signs depending on the species infected.  In cattle 
(most common species infected) the disease can remain latent until it is in the final stages or 
not diagnosed until necropsy.  This allows the disease to remain in the environment  and have a 
prolonged period of transmission.   
DISEASE OVERVIEW 
J. Agent: 
Mycobacteria are non-motile, rod shaped, obligate aerobic bacteria classified as acid 
fast because they have thick, waxy cell walls that are impermeable to stains and dyes.  
There are more than 120 species and most are not considered pathogenic.     
 
K. Clinical Description: 
Signs include but are not limited to: progressive weakness, anorexia, cough, difficulty 
breathing, lymphadenitis, draining sinus tracks, diarrhea and constipation.  
 
L. Reservoirs: 
M. bovis  hosts are variable,(usually cattle, bison and humans). 
M. avium  hosts are birds. 
M. tuberculosis hosts are humans.  
M. caprae  hosts are goats, cattle, pigs and humans. 
 
M. Mode of Transmission: 
Transmission occurs through inhalation of infected droplets.  It can also occur through 
direct contact with infected animals’ fluids and/or tissues. Airborne transmission may 
occur through inhalation of aerosols in lab settings. Ingestion is another route of 
transmission through sharing of feeders, waterers or other equipment.   
 
 
N. Incubation Period: 
Variable incubation period, ranging from 7 to 60 days, but may be several months; 
illness is extremely variable. Many animals will be infected but may never show clinical 
signs.  
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O. Period of Communicability: 
Animals may be infectious for years. 
 
P. Susceptibility and Resistance: 
Susceptibility in humans is determined by occupation; there is no documented case of 
being resistant to the bacterium. 
 
Q. Treatment: 
Treatment is not recommended for animals and slaughter is advised. In non-herd 
situations, like a zoo animal, or where the animal is considered a significant economic 
loss pharmacotherapy has and can be used.    
 
R. Vaccine: 
There is no vaccine currently available.  
NOTIFICATION TO PUBLIC HEALTH AUTHORITIES 
Tuberculosis infections shall be designated as infectious or contagious in their 
nature, and cases or suspect cases shall be reported within seven days: 
 
1. Health care providers and hospitals: report to the local public health 
Jurisdiction, KDA-DAH, or KDHE-BEPHI (see below) 
2. Local public health jurisdiction: report to KDA-DAH or KDHE-BEPHI (see below) 
3. Laboratories: report to KDA-DAH or KDHE-BEPHI (see below) 
4. KDA-DAH or KDHE-BEPHI will contact the local public health jurisdiction by phone 
within one hour of receiving any suspected tuberculosis report. 
 
Kansas Department of Agriculture – Division of Animal Health (KDA-DAH) 
Phone: 1-785-296-2326 
Fax: 1-785-296-1765 
Kansas Department of Health and Environment (KDHE) 
Bureau of Epidemiology and Public Health Informatics (BEPHI) 
Phone: 1-877-427-7317 
Fax: 1-877-427-7318 
 
Outbreaks, unusual occurrences of brucellosistuberculosis, and suspect acts of terrorism 
should be reported WITHIN 4 HOURS by telephone to 1-877-427-7317. 
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INVESTIGATOR RESPONSIBILITIES 
1) Use current case definition, to confirm diagnosis with the medical provider. 
2) Conduct a case investigation to identify potential source of infection. 
3) Conduct contact investigation to identify additional cases. 
4) Identify whether the source of infection is major public health concern. 
5) Initiate control and prevention measures to prevent spread of disease. 
6) Complete and report all information requested via the state electronic surveillance system. 
7) As appropriate, use the disease fact sheet to educate individuals or groups. 
STANDARD CASE INVESTIGATION AND CONTROL METHODS 
Case Investigation 
1) Contact the veterinarian who ordered testing of the case and obtain the 
following information. (This includes medical records for hospitalized patients.) 
 Using the case report form, identify any symptoms of tuberculosis: 
− Record onset date (if a reoccurrence – record the earliest onset date) 
− Record the duration of the current illness in weeks 
− Determine if the onset was acute or insidious, recording symptoms 
 Examine the laboratory testing that was done to ensure all testing that could 
confirm the case has been reported in Epi-Trax. 
 Examine and record the therapy that the case received, if any. 
 Collect owner’s demographic data and contact information (birth date, county, 
sex, occupation, address, phone number(s)) 
 Record outcomes: recovered or date of death 
2)  Interview the owner to determine source and risk factors; focus on a 6 
month incubation period prior to illness onset. 
 Occupation: Laboratory worker, veterinarian, or persons handling animals and animal 
by-products 
 Contact with potentially infected animals or their tissues 
3) Investigate epi-links among cases (clusters, household, co-workers, etc). 
 For suspected outbreaks refer to Managing Special Situations section. 
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Contact Management 
1) Symptomatic acquaintances, household members, associates, or co-workers should be 
strongly urged to contact their physician for a medical evaluation. 
 
Environmental Measures 
1) Exercise care when handling suspect animals. 
2) Disinfect contaminated areas with a bleach solution or other commercial disinfectant. 
 
Education 
1) Educate high-risk workers (i.e., veterinarians, owners, handlers, etc.) about 
the risk of tuberculosis and stress methods to reduce occupational exposure 
such as proper ventilation, appropriate carcass disposal and barrier precautions. 
 
MANAGING SPECIAL SITUATIONS 
 
A. Outbreak Investigation: 
There are no formal outbreak definitions; however, the investigator may consider the 
possibility of an outbreak when there is an unusual clustering of cases in time and/or space. 
1) Notify KDA-DAH (785 296 2326) or KDHE (1-877-427-7317) immediately. 
2) Active case finding will be an important part of any investigation. 
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Diagnosis: 
 Veterinarians who suspect brucellosis should promptly collect samples for culture 
 Alert the laboratory to the possibility of Tuberculosis and need for safety procedures. 
 Detection of M. bovis DNA in a clinical specimen by polymerase chain reaction (PCR) 
assay 
 A suspect case is a case that is epidemiologically linked to a confirmed case.  
 
Treatment: 
No treatment is suggested.  
 
 
C. Laboratory Exposure to Tuberculosis isolates: 
1) Determine number of workers exposed to isolates and classify exposures into high- 
and low-risk. 
2) Recommend PEP for workers with high-risk exposures to Tuberculosis. 
3) Discuss PEP with workers with only low-risk exposures. 
4) Obtain baseline serum samples from all workers as soon as possible after 
potential Tuberculosis exposure is recognized.  
5) Arrange for regular active surveillance for the development of febrile illness 
(for 4 weeks) or other signs and symptoms of tuberculosis(for 12 months). 
 
DATA MANAGEMENT AND REPORTING TO THE KDA-DAH & KDHE 
 
A. Organize and collect data. 
 
B. Report data via the Kansas electronic surveillance system. 
• All essential data that was collected during the investigation, especially data that helps 
to confirm or classify a case. 
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Tuberculosis Fact Sheet 
Introduction 
Tuberculosis is a contagious disease caused by an infection in the lymph nodes which is then 
spread to other organs like the lungs. This disease can infect all mammals, and before control 
measures were adopted, was one of the major diseases of humans and domestic animals.   
 
Transmission 
Transmission in cattle typically occurs by inhalation; cattle with lung lesions will cough and 
spew infected airborne droplets.  Herd mates will inhale these droplets and become infected.  
Cattle can also become infected by using contaminated feeders and waterers.  Baby calves can 
acquire the infection via milk from infected mothers.  The movement of infected cattle into 
different herds is the most common way the disease spreads.  Cattle that have prolonged close 
contact have an increased risk.  Bovine tuberculosis can produce infection in humans even 
though most human tuberculosis infections are caused by a different subspecies.  Anyone who 
is in close contact (owners, handlers, veterinarians) with infected cattle can become infected. In 
suspect human infections, their physician should be contacted.    
 
Clinical Signs in Ruminants 
Bovine tuberculosis is usually a slowly progressive and debilitating disease, but can occasionally 
have a quick onset and progress rapidly. Early stages of the infection often show no signs. As 
the disease progresses, weight loss, lack of appetite, weakness, and a low-grade fever are 
common. If the disease involves the lungs, animals will have a cough that is worse in the 
morning, during cold weather or activity, and they may have difficulty breathing. If the digestive 
tract is involved, animals may develop diarrhea that comes and goes or may become 
constipated. Ruminants are the most susceptible to tuberculosis. Infections have also been 
described in many other animals including sheep, goats, horses, pigs, deer, dogs, cats.  
 
Diagnosis and Treatment 
Cattle are usually screened/diagnosed via the tuberculin skin test or through PCR testing. 
Tuberculosis is a federally regulated disease and veterinarians must report suspected cases. 
Animals in states where there has been TB diagnosed in the last year have to perform a skin 
test to see if they have been exposed. If the animal is found positive, slaughter is recommended 
and an epidemiological investigation will need to be completed.  Some wild animal species (e.g. 
deer, elk) can serve as reservoirs for bovine tuberculosis, so limit their contact with cattle. 
There is not an effective vaccine and treatment is not advisable.  
Control 
 Quarantine of the premises should be instituted immediately 
 Positive animals should be sent to slaughter 
 Appropriate decontamination of pens, panels and equipment  
 Isolate other sick animals 
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 Test all animals prior to adding them to your herd 
 Continue testing before quarantine is released if not all animals are euthanized 
This fact sheet is for information only and is not intended for self-diagnosis or as a substitute 
for consultation. If you have any questions about the disease described above or think that your 
animal may have an infection, consult with your veterinarian. 
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Appendix I-3 
Tuberculosis Case Report Template 
Case Report Tuberculosis 
Demographics 
Case # 
Investigator- 
 Name 
 Email 
 Phone # 
Veterinarian-  
  Name 
 Address 
  Cell # 
 Work # 
 Email 
 Clinic name 
Owner- 
 Date reported 
 Name 
 Address 
 County 
 DOB 
 Home # 
 Cell # 
 Work # 
 Email 
 Gender 
 Primary language 
Other Contacts- 
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Any other humans in contact with suspect animal? 
 Name 
 Address 
 Phone 
 Date of contact with suspected animal 
 Type of contact 
Animal Demographics 
Species 
Breed 
Gender 
State of Origin 
Age at disease onset 
Quarantined 
Deceased 
Was animal euthanized- 
Was animal sent to slaughter-  
Were other animals exposed to the suspect animal 
 If yes, are they sick or showing the same clinical signs  
 If no, were they isolated from the suspect animal 
Are other animals eating  or have access to the same feeders, waters or other equipment  as 
the suspect animal? 
Exposure History 
How long has the animal been owned by the current owner? 
Where did owner get animal? 
Other animals that are in contact with currently sick or dead animal? Please describe 
 If yes, what species, how many, type of contact 
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Other animals with the same or similar clinical signs 
 If yes, please complete an additional form for each animal 
Any other animals before now (days, week, months, years) become sick or die with similar 
clinical signs 
Where has the animal been housed, located or pastured for the last 60 days 
Has the animal traveled in the last 60 days 
 If yes, please explain where, for what purpose and for how long 
Is there any known illness in humans that have handled or been around the animal 
If the animal died, was a necropsy preformed?  
Results or what was found? 
 If yes, please list name, address, phone of who completed necropsy 
Laboratory information 
Name 
Number 
Specimen collection date 
Specimen collected 
Who collected specimen 
 Name, number  
 Was personal protection utilized to collect specimens? 
  If yes, please explain 
Name of test  
Result of test 
Date medical care sought 
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Symptomatic: 
 weakness 
 Hacking cough 
 Difficulty breathing 
 Fever 
 Depression 
 Lymphadenopathy 
 Off feed 
 Weight loss 
 Constipation 
 Chronic diarrhea 
 Mucus discharge from nose 
 Rapid decrease in milk production 
 Other, please explain 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
